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ABSTRACT 
 
Anti-inflammatory Properties of Citrus Limonoids and Their Isolation and 
Characterization. (December 2011) 
Jin Hee Kim, B.S., Sahmyook University; M.S., Chung-Ang University 
Chair of Advisory Committee: Dr. Bhimanagouda S. Patil 
 
 
This dissertation investigates the role of limonoids in inflammation to reduce risk 
of breast cancer and cardiovascular disease. Radical scavenging activity and apoptotic 
effects of extracts from lemon seeds were investigated in human breast adenocarcinoma 
(MCF-7) cells and non-malignant breast (MCF-12F) cells. The MeOH:water (80:20) 
extract showed the highest (29.1%, P < 0.01) inhibition of MCF-7 cells without affecting 
the non-malignant breast cells. Further, the purified and modified limonoids were 
screened for their cytotoxicity on estrogen receptor (ER)-positive (MCF-7) or ER-
negative (MDA-MB-231) human breast cancer cells. The MCF-7 cell was more 
susceptible to tested limonoids. Although most of limonoids induced anti-aromatase 
activity, the inhibition of proliferation was not related to the anti-aromatase activity. On 
the other hand, the anti-proliferative activity was significantly correlated with the level 
of caspase-7 activation by limonoids.  
The next study investigated the mechanism of anti-breast cancer and anti-
aromatase activities of obacunone through inhibition of MCF-7 cell proliferation without 
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affecting non-malignant breast cells. Treatment with obacunone resulted in an increased 
G1 cell cycle arrest and induction of apoptosis. Exposure of MCF-7 breast cancer cells 
to obacunone down-regulated expression of inflammatory molecules including nuclear 
factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2). Furthermore, potential of 
obacunone on inhibition of COX-2 and NF-κB by a mechanism involving activation of 
the p38 mitogen-activated protein (MAP) kinase was also investigated.  
In the final study, nomilin was the most potent natural inhibitor for p38 MAP 
kinase activity in human aortic smooth muscle cells indicating that a seven-membered A 
ring with acetoxy group, present in nomilin, seems to be essential for its inhibitory 
activity on p38 MAP kinase. The possible mechanism of nomilin for prevention of 
cardiovascular disease was determined. Pre-treatment with nomilin resulted in 
significant inhibition of TNF-α induced HASMCs proliferation. The anti-proliferative 
activity of nomilin is due to apoptosis through mitochondrial dependent pathway.   
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1. INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Background 
Citrus is grown commercially in more than 140 countries around the world (1). 
Citrus production has shown increased demand for fresh juices and the processed 
market. Among citrus fruits, oranges, grapefruits, and lemons are considered to be the 
top three fruits for expanded consumption (1). Furthermore, lemons are widely used 
citrus crop for food additives, food products (essential oils, gum/resin, lipids), medicines 
folklore, and have shown to possess several potential health benefits. In the United 
States, lemon produced mainly in California and Arizona states (2). Per capita 
consumption of lemon is estimated to be 8.6 pounds in United States (3). Despite several 
uses of lemons, very little information is available about health benefits of lemon as 
compared to the other citrus fruits such as oranges and grapefruits. 1 
Epidemiological studies have demonstrated the inverse correlation between 
increasing consumption of fruits and vegetables and incidences of human diseases such 
as cancer and heart disease (4, 5). Citrus fruits are rich in health-promoting 
phytochemicals. Limonoids constitute one of the major phytochemicals along with 
flavonoids, coumarins, and carotenoids in citrus (6). Citrus limonoids are a class of 
secondary metabolites known as triterpenoids, and act as a defense agents against 
insects. Until now, 62 limonoids, including 44 aglycones and 18 glucosides, have been 
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identified from citrus fruits, and still the number is increasing (7-9). The early research 
focused on the identification of limonoids because of the delayed bitterness caused by 
certain limonoids such as limonin and nomilin. Limonin and other bitter limonoids were 
considered as an undesirable component to maintain the acceptable-quality level for the 
fresh or processed juice industry. However, recent research has discovered the various 
health benefits and pharmacological uses of limonoids such as anti-bacterial, anti-fungal, 
anti-viral, anti-oxidant, anti-inflammation, and anti-cancer (6, 8, 10). Additionally, 
consumption of about seven glasses of orange juice that contain 320 mg/L of limonoid 
glucosides is found to be nontoxic (11).  
Limonoids were shown to possess anti-cancer properties. In the past quarter 
century, accumulated evidences advanced our understanding about the disease 
prevention mechanism of limonoids (12). It is speculated that limonoids suppress cell 
proliferation and induce apoptosis by inhibiting enzyme activities and signal 
transduction pathways. Several in vitro studies associated with citrus have demonstrated 
its antioxidant, anti-proliferative effects and its protective effects on cardiovascular 
disease and many other diseases (6, 13-16). In addition, limonoids were also shown to 
inhibit cell metastasis in cell culture and animal studies. However, further research is 
required to identify the cellular targets of active limonoids. Identification of the target 
mechanism at cellular level may result in the development of limonoids as anti-cancer 
agents. 
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1.2 Biosynthesis of Citrus Limonoids 
Triterpenoids are the largest group of plant secondary metabolites, and over 4000 
triterpenoids have been identified in the plant kingdom (17). The limonoids are 
biosynthesized in the cytosol and distributed in different parts of plant such as seed, stem 
bark, leaf, and fruit (18). The biosynthesis occurs based on the “biogenetic isoprene 
rule” (19). Isopentenyl diphosphate (IPP) and its allylic isomer dimethyl allyl 
diphosphate (DMAPP) are common precursors of isoprene biosynthesis. The limonoids 
are synthesized via a mevalonate pathway to produce triterpenoids (20). The 
triterpenoids consist of 30 carbons and are derived from squalene (21). Limonoids are 
degraded triterpenoids, also called tetranotriterpenoids, consist of a furan ring attached at 
C-17 and contain a functional group at C-3, C-4, C-7, C-16, C-17, and C-19 (8, 21). The 
limonoids are synthesized by squalene through oxidation and the rearrangement process 
and the basic skeleton come from euphol or tirucallol, which are considered precursors 
of limonoids (21). 
By using radioactive tracer techniques, citrus metabolites were shown to possess 
two distinct precursors during limonoid biosynthesis. In principle, deacetylnomilinic 
acid is a precursor of limonoids in Citrus which gets converted to nomilin in the phloem 
region of the stem (22). In addition, stem tissue synthesizes nomilin directly from acetate 
(18). The synthesized nomilin is translocated from the stem to other parts of the plant, 
such as leaves, fruit, seed, and root tissues. Other limonoids are biosynthesized from 
nomilin in all the region of the plant except the cortex and inner core (18).  
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Citrus limonoids are present in the glucoside or aglycone. The aglycones are 
converted to glucosides by the UDP-D-glucoside: limonoid glucosyltransferase enzyme 
during the fruit maturation process (23). Higher concentration of total limonoids were 
found in the seeds as compared to fruits, suggesting that seeds act as sink for these 
compounds (24). However, the glucosides concentration is less than half of the 
aglycones in the seed (24).  
 
1.3 Stability and Bioavailability of Citrus Limonoids 
In addition to ascorbic acid, citrus contains flavonoids, carotenoids, coumarins, 
volatile oil, sitosterols, pectin, and limonoids (6, 25). Limonoids are present as 
glucosides as well as aglycone form. The solubility and bioavailability are often 
considered an important factor to improve the health effects of bioactive compounds. 
Accordingly, the identification of digestive metabolites, intracellular metabolism, plasma 
transport, and toxicity has been intensively studied for understanding the bioavailability 
properties (8, 15, 26). The limonin and limonin glucoside are the predominant limonoids 
in orange juice, and the limonoid glucosides concentration ranges between 350 and 400 
ppm (27). Due to the bitterness of limonin, the levels of limonin are considered an 
important quality attribute of the citrus processing industries. The bitterness threshold of 
limonin in orange juice is 6.5 ppm, and the threshold is maximized at pH 3.8 because the 
optimum pH suppresses the limonin bitterness (28). The stability and degradation of 
limonin during juice processing need to be investigated. The limonin is a highly heat-
stable and the chemical structure is stable up to 298°C (29). The stability and 
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decomposition rate of compounds could be affected by several factors such as humidity, 
temperature, pH, and oxygen level. Limonin is stable over a wide range of pH value (pH 
2-9) and most stable at pH 5 at 45 ºC (18). However, the limonin is completely degraded 
at pH 10-12. On the other hand, the limonin produces an isomer named limonexic acid 
due to the effect of strong acids on the furan ring (29). Moreover, the limonin stability 
was affected by temperature in acidic and basic conditions. The limonin exhibited 
maximum stability at 45ºC compared to 70-80 ºC (29).  
Several studies have been focused on understanding the bioavailability and 
toxicity of natural products due to the chemopreventive efficacy depending on its 
absorption, metabolism, and safety (30, 31). However, only one study was conducted on 
the bioavailability of limonoids till date. The limonin glucoside, upto 2 g/per day, was 
fed to the subjects and metabolites were measured in the plasma using LC-MS technique 
(10). The results of the study suggested that the limonin glucoside was converted into 
limonin as final metabolite with maximum plasma concentration at 6 h (10). During the 
experiment, epilimonin, which is an isomer of limonin, was also detected indicating 
presence of an additional metabolite. (32). Although there are limited human 
intervention studies on absorption of citrus limonoids, investigations using soy 
phytochemicals suggest that aglycones show much faster and higher absorption rates 
than glucosides in humans (33). 
In addition, several toxicity studies were reported using animal models. Miller et 
al. (26) investigated the long term feeding of limonoids mixture on weight gain in 
pregnant rats. These results demonstrated that diet supplement with limonoids (0.25% 
  
 
6 
6
 
and 0.15%) caused a significant reduction in weight gain in female and male progeny, 
respectively (26). Even though the results suggest the exposure of high concentration of 
limonoids causes problem with weigh gain, such a correlation need to be determined in 
humans. For instance, daily consumption 130 glasses of orange juice for one week is 
required to reach a similar level for a 60 kg adult (26).  
 
1.4 Cancer Chemoprevention by Citrus Limonoids  
More than 290 bioactive compounds have been reported so far in citrus species, 
including 115 carotenoids (34), 60 flavonoids (34, 35), 62 limonoids (36), 31 volatile 
oils (37), 17 coumarins (38), and 6 amines (39). Due to the presence of these 
compounds, citrus is considered one of the promising healthy food. For instance, 
limonoids have shown strong activity to suppress tumor formation in a various cancers, 
reduce risks of heart disease, neurodegenerative disease, and autoimmune disease (6, 15, 
40, 41). Among the chronic diseases, cancer is one of the common malignant, and more 
than 13% of human deaths (7.6 million) are associated with cancer in the world. In USA, 
approximately 560,000 Americans, more than a quarter-percent of the USA population 
die from cancer (42-44). However, the complexity of the disease, mortality, and 
morbidity of cancer, the mechanism of tumor formation and resistance to therapy is 
poorly understood. Interest in preventive therapies using a nutritional approach is now 
increasing as these alternative approaches may help in delaying the progression of 
carcinogenesis.  
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Limonoids have been identified for their anti-carcinogenic activity in cell 
cultures and animal model systems. The potential of an anti-carcinogenic property of 
limonoids from citrus species is being actively investigated in the colon cancer. 
Glutathione S-transferases (GST) are an important catalytic and binding protein family 
due to its ability to detoxify carcinogens (45). In 1989, Lam and coworkers reported the 
induction of GST enzyme in small intestinal mucosa by nomilin and limonin (46). In 
another study, while limonin showed minimal effect, nomilin increased the GST activity 
three times compared to the control group. Furthermore, recent study from Patil‟s lab 
demonstrated that a limonin analogue, limonin-7-methoxime was a potent inducer of 
GST in mice (47). Further, in 1994, it is demonstrated that limonin and nomilin suppress 
chemically induced tumor size in an animal model (48). Additionally, obacunone and 
limonin have shown the ability to inhibit formation of aberrant crypt foci (ACF) in 
azoxymethane (AOM) induced colon cancer model in rats (49). After 4 years, in 2005, 
limonin demonstrated the suppression of chemically induced ACF formation in similarly 
designed animal experiment (50). Based on the results, the authors speculated that the 
possible mechanism may be apoptosis mediated by down-regulation of inducible nitric 
oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), which are involved in the 
inflammatory process (50). Furthermore, limonoid aglycones such as limonin, nomilin, 
obacunone, and deacetyl nomilin showed anti-proliferative activity through induction of  
caspase 3/7 in colon carcinoma Caco-2 cells (51). In addition, ichanexic acid and 
isolimonexic acid  inhibited the G2/M phase, inducing cell cycle arrest in human colon 
adenocarcinoma HT-29 cells (7). More recently, limonexic acid was shown to induce 
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cell cycle arrest in human colon adenocarcinoma HT-29 cells (52). Taken together, these 
results indicated that cell cycle arrest and apoptosis through inhibition of iNOS/COX-2 
expression and induction of caspase 3/7 might be considered a mechanism by which 
limonoids may exhibit chemopreventive property in colon cancer.  
Limonoids were reported to inhibit the cell proliferation in  MDA-MB-435 
estrogen receptor-negative (ER-) and MCF-7 estrogen receptor-positive (ER+) breast 
cancer cell lines (16, 53). However, the anti-proliferative activity by limonoids in breast 
cancer cells and the mechanism of cell growth inhibition by limonoids remains to be 
elucidated. Recent studies from Patil‟s lab and elsewhere reported that limonin and 
nomilin could inhibit cancer development in the neuroblastoma (51, 54), pancreatic in 
vitro (36), stomach, lung, and skin in vitro and in vivo (40). Furthermore, we also 
showed that obacunone induces apoptosis and inhibits inflammatory markers in 
pancreatic cancer Panc-28 cells (55).  
  Human cytochrome P450 oxidoreductase enzymes (CYPs) known to involve in 
drug metabolism, degradation of xenobiotics, and detoxification processes (56). Several 
studies have demonstrated that the overexpression of the CYPs has strongly associated 
with cancer susceptibility (56). The limonoids were evaluated as potent inhibitor of 
CYPs (57, 58). Fukuda et al. (57) found that the limonin and obacunone were potent 
inhibitor of cytochrome P450 monooxygenase 3A4 (CYP3A4) in rat and human liver 
microsomes. Furthermore, our recent study also indicated that nomilin, NAG, and LG is 
a potent inhibitor of CYP3A4 activity (58). However, the specific interaction of 
limonoids and CYPs is remained to be elucidated.   
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1.5  Structure-Activity Relationship of Limonoids 
  The structure-activity relationship of bioactive compounds is an important 
parameter for understanding the biological activity. Recent our results suggest that the 
presence of furan and an intact A ring structure are responsible for chemopreventive 
activity in cancer cells. For example, furan ring seems to play an important role in anti-
proliferative activity of Panc-28 cells (36). In particular, the configuration of furan ring 
is critical for action. This is exemplified by the difference in activities of isolimonexic 
acid and limonexic acid, which differ in the configuration of furan ring. Other critical 
factors seem to be A-ring and glucose moiety. A-ring also seems to play important role 
in anti-proliferative activity of limonoids against MCF-7 cells (16). Specifically, 
presence of 7-membered A-ring (obacunone and nomilin) imparts higher activity 
compared to presence of A and A  ´ring present in limonin. 
 
1.6 Other Biological Activities of Citrus Limonoids 
Limonoids exhibited anti-HIV, moderate radical scavenging, and anti-oxidant 
activity (54, 59). Recent studies have demonstrated the anti-microbial, anti-bacterial, and 
anti-fungal activity of limonoids in the khaya species, as well as in several other plants 
found in the Rutaceae family (8). For the first time, Patil‟s lab reported that certain citrus 
limonoids inhibit bacterial cell-cell signaling and biofilm formation (60, 61). Specially, 
obacunone was the most potent inhibitor of Escherichia coli O157:H7 biofilm formation 
(61). Michael et al. reported the structure-activity relationships of limonoids on anti-
feedant activity (62). The results demonstrated that the furan ring and the epoxide group 
  
 
10 
1
0
 
have the highest activity against insects (62). Furthermore, studies have shown that the A 
ring of the limonoid nucleus may be a key regulator for anti-neoplastic activity and 
cancer chemopreventive activity (63, 64) whereas, the D ring may not be associated with 
biological activity (15, 65). Therefore, the structure-function activity of limonoids plays 
a vital role in understanding their biological action. More extensive research is required 
to understand the mechanism of proliferation inhibition by structurally related limonoids. 
 
1.7 Role of Inflammation in Breast Cancer and Cardiovascular Disease 
Inflammation is triggered in response to many genetic, familial, hormonal, and 
environmental factors and plays a role in many disease initiation and progression 
including breast cancer and cardiovascular disease (66). Pro-inflammatory factors, such 
as the transforming growth factor (TGF)-β, platelet derived growth factors, macrophage 
inhibitor factor (MIF), chemokines, cytokines, interferon gamma, and monocyte 
chemoattractant protein (MCP-1) play a role in the development of cell proliferation and 
cell migration (67-69). However, overproduction of these inflammatory factors have 
been implicated in inducing a variety of cancer and chronic cardiovascular diseases such 
as atherosclerosis, coronary artery disease, arrhythmia, heart failure, hypertension, and 
ischemia (68, 70-72). Therefore, chronic inflammation has been thought as a possible 
mechanism link between cancer and cardiovascular disease.  
 Breast cancer is one of the most common cancers among women. Unfortunately, 
reducing the risk of breast cancer is difficult due to the fact that most cases involve 
complex hormonal responses, increased obesity rates, and high blood estrogen levels for 
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postmenopausal women (73). Hormone sensitivity has been found to be one of the key 
signatures in breast cancer diagnosis (73). More than 60% of breast tumors exacerbated 
by excessive estrogen and the presence of estrogen receptors (ER) result in better 
prognosis than ER-negative (74). Although the ER positive breast tumors are more 
responsive to chemotherapy than negative breast tumors, the outcome of anti-cancer 
agents are not always followed by same mechanism due to the complex interaction of 
anti-cancer and human disease. After the discovery in 1973 of the biochemical 
interaction of the ERα with hormones (75), ERα antagonists, including tamoxifen and 
letrozole, were utilized for the treatment of breast cancer. While hormone therapy is 
currently the most prevalent breast cancer treatment, new models need to be explored 
(76).          
 The smooth muscle cells (SMCs) are closely related to the initiation of 
atherosclerosis and are involved in the disease‟s progression (77). The proliferation of 
SMCs is a key feature of development of the early atherosclerosis stage (77). Diverse 
signaling pathways such as mitogen activated protein kinase (MAPK), phosphoinositid 
(PI)-3 kinase, nuclear factor (NF)-КB, protein kinase C (PKC), and several growth 
factors indicate the progression of SMCs (78). Inflammatory responses continuously 
stimulate the migration and proliferation of SMCs, which results in accumulation of 
extracellular matrix and the thickening of the artery wall (78). 
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1.8 Alteration Cell Behavior and Apoptosis 
Apoptosis is a regulated (or programmed) form of cell death that controls cellular 
organism through eliminating damaged or unwanted cells. These death signals lead to 
characteristic morphological changes such as membrane blebbing, chromosomal DNA 
fragmentation, and chromatin condensation (79). The cell death triggers through 
different signaling pathway in mammalian cells. Proper regulation of apoptosis allows 
counter balance of cell numbers and tissue size, and appropriate cellular homeostasis 
during the developmental and physiological process. A family of proteins known as 
caspases (cysteinyl aspartate-specific proteases) is key regulator that cleaves their 
substrates after an aspartate residue in early stage of apoptosis (80). There are two 
distinct classes of caspases: the initiator caspases, which include caspase-2, -8, -9 and -
10 in mammals and the effector caspases, which include caspase-3, -6, and -7 in 
mammals (80).  
Most caspases are synthesized as catalytically inactive zymogens and undergo a 
process of proteolytic activation during apoptosis (81). The initiator caspases are auto-
activated under apoptotic conditions (81). The activation of an initiator caspase triggers a 
cascade of downstream caspase (called effector caspase) activation. As the activated 
caspases undergo proteolytic processing, a variety of cellular proteins are degraded 
during cell death (81). Dysregulation of apoptotic contributes to a number of human 
diseases including cancer, cardiovascular disease, autoimmune disorders and 
neurodegenerative diseases (82). Previous studies have shown that limonoids inhibit 
proliferation in different cancer cells. However, it is still unclear how limonoids are 
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regulating apoptosis mechanism. Therefore, further experiments are required to 
completely understand the function of limonoids in apoptotic cells. 
 
1.9 Research Objectives 
The main goal of this research is to determine the role of health promoting 
properties of limonoids from lemon in inflammatory disease such as breast cancer and 
cardiovascular disease, and to investigate the mechanism of the biological activities of 
limonoids relating to their potential in breast cancer and cardiovascular disease 
prevention. Additionally, structure-activity relationship of limonoids was demonstrated 
to determine the potential use of limonoids for human health. More specifically, the 
research objectives are as follows: 
 Bioassay-derived isolation and purification of antioxidant potential and growth 
inhibition of human breast cancer and non-malignant cells using different polar 
extracts from lemon seed. 
 Purification and characterization of aglycones and glucoside of limonoids using 
chromatographic techniques.  
 Screen the potential biological activity in human breast cancer cells and 
delineate the possible mechanism underlying the inhibition of human breast 
cancer cell proliferation by limonoids.  
 Investigate the possible downstream pathways to understand the mechanism of 
limonoids-induced inhibition of breast cancer cell growth. 
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 Elucidate the structure-function activity of limonoids on p38 mitogen activated 
protein kinase activity in human aortic smooth muscle cells.  
 Explore the possible inhibition mechanism by nomilin on TNF-α induced 
HASMCs proliferation.    
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2. BIOASSAY-DERIVED PURIFICATION OF LEMON SEED EXTRACTS2* 
 
2.1 Introduction 
Epidemiological studies have demonstrated the inverse correlation between 
increasing consumption of fruits and vegetables and incidences of breast cancer risk (4, 
5). Recent cohort studies reported that fruit and vegetable consumption may not have a 
significant effect in reducing the risk for breast cancer (83). However, different bioactive 
compounds derived from fruits and vegetables, including flavonoids (84, 85), 
polyphenols (86), and vitamins (87, 88), have been evaluated for inhibition of breast 
cancer cell growth and metastasis inhibition using in vitro and in vivo model systems. 
Despite conflicting reports, fruits and vegetables are commonly recognized for their 
health benefits. While this is well understood, the mechanisms by which certain 
bioactive compounds in fruits and vegetables reduce the risk of cancer, as well as their 
absorption by the human body, have yet to be determined. 
Citrus fruits, as a major contributor to human diet, have received attention by 
researchers due to their multitude of bioactive compounds. Recent in vitro studies 
suggested that several bioactive compounds from citrus contain many other health-
promoting properties and have potential relevance for antioxidant, anti-proliferative, and 
anti-viral agents, as well as for the prevention of cardiovascular disease (8). In our 
previous studies, bioactive secondary metabolites from citrus, such as limonoids, 
                                                 
2
* Reprinted with permission from “Evaluation of chemopreventive and cytotoxic effect of lemon seed 
extracts on human breast cancer (MCF-7) cells” by Jinhee Kim, Guddadarangavvanahally K. Jayaprakasha, 
Ram M. Uckoo, and Bhimamagouda S. Patil, Food and Chemical Toxicology, In press. 
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flavonoids (naringin), and carotenoids (lycopene, lutein), were shown to suppress the 
growth rate of human breast cancer (16), colon cancer (7, 52, 89), neuroblastoma cells 
(51), and rat prostate carcinoma cells (90) using in vitro models, as well as 
azoxymethane-induced aberrant crypt foci in an in vivo study (50).  
Apoptosis is an important regulatory mechanism in the development of tissues, 
involving biological events such as chromosome condensation, DNA laddering, 
membrane blebbing, and cytochrome C release, which leads to the removal of 
unnecessary cells (80). It is well known that cancer is due to mitochondria-generated 
reactive oxygen species (ROS) and DNA damage, apoptosis, or necrosis (91). 
Furthermore, studies have supported that ROS production, lipid peroxidation, and 
mitochondria function are related to many diseases, including cancer, diabetes, and 
neurodegenerative disorder (92). Recently, our studies have provided clear evidence that 
certain citrus bioactive compounds induce significant increases in the activity of 
detoxifying enzymes such as glutathione S-transferase and quinone reductase (47).  
Citrus is grown commercially in more than 140 countries around the world. 
Among citrus, oranges, grapefruits, and lemons are considered to be the top three fruits 
for consumption throughout the world (1). Lemons are widely consumed as culinary 
fruit, and their economic importance has steadily increased due to the fresh fruit juice 
industry, medicinal folklore, and the ingredients market. During the processing of 
lemons, more than 50% of the fruit weight is discarded as waste (93). Byproducts such 
as molasses, seeds, and peels are being used for animal feed, health beneficial 
compounds (94), and fuel utilization (95). On the other hand, among the different parts 
  
 
17 
1
7
 
of the lemon fruit, seeds are one of the major byproducts which do not have significant 
use. The current research is an attempt towards making use of the seeds for 
understanding role of seeds. This will add economic benefits to citrus processing 
industry, citrus growers, and human society. Based on this information, we focused on 
evaluating the bioactivity of the lemon seeds. Despite several uses of lemons, very little 
information is available about the health-promoting properties and the mechanism of 
action of lemon bioactive components compared to other citrus fruits such as oranges 
and grapefruits.  
To the best of my knowledge, no reports are available on lemon bioactive 
compounds and their effects on the growth of human breast cancer and non-malignant 
cells. Therefore, this study investigated the antioxidant potential and growth inhibition of 
human breast cancer and non-malignant cells using different polar extracts from lemon 
seed. The chemical composition was identified by LC-MS.  
 
2.2 Materials and Methods 
2.2.1 Chemicals 
All solvents used in this study were analytical and HPLC grade (EDM Chemical 
Inc., Gibbstown, NJ). The following chemicals were purchased from Sigma (St. Louis, 
MO): 1, 1-diphenyl-2-picryl hydrazyl (DPPH); 2,2'-azino-di-(3-ethylbenzothiazoline)-6-
sulfonic acid (ABTS
.+
) Folin-Ciocalteu; Dulbecco‟s Modified Eagle Medium (DMEM); 
trypsin-EDTA; penicillin; streptomycin; 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT); and dithiothreitol (DTT). Fetal bovine serum (FBS) 
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was purchased from Gibco (Grand Island, NY). Human breast cancer MCF-7 and MCF-
12F non-malignant cell lines were obtained from the American Type Culture Collection 
(ATCC) (Manassas, VA). A cell fractionation kit was used to obtain the cytosolic 
cytochrome C extract (Bio-Vision incorporated, Mountain view, CA). Mouse 
monoclonal anti-Bax (sc-7480), anti-Bcl2 (sc-65392), anti-cytochrome C (sc-13156), 
and anti-β-actin (sc-81178) were obtained from Santa Cruz Biotechnology (Santa Cruz, 
CA), and rabbit polyclonal anti-PARP (#9542) was purchased from Cell Signaling 
Biotechnology (Beverly, MA). Other chemicals and biochemical materials were 
purchased with the highest available purity.  
 
2.2.2 Preparation of Lemon Seed Extracts  
Dried lemon seeds (3 kg) were powdered and extracted with hexane in a Soxhlet 
extractor for 8 h to remove fatty material. The defatted powder (2.4 kg) was extracted 
sequentially with 6 L of ethyl acetate (EtOAc), acetone, methanol (MeOH), and 
MeOH:water (80:20) for 16 h each, successively. Each extract was concentrated by a 
rotary evaporator (Büchi, Switzerland) under a vacuum to obtain viscous liquid and 
stored at -20 °C until the analysis (Labconco Corp., Kansas, MO).  
 
2.2.3 Identification by LC-MS  
Lemon seed extracts were dissolved in either acetone or MeOH:water (1:1), 
filtered by a 0.45 µm membrane filter (Millipore Co., Bedford, MA) and analyzed by 
LC-MS. The LC system consisted of Finnigan Surveyor plus (West Palm174 Beach, FL) 
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coupled to a mass spectrometer-Ion Trap (LCQ-DECA, ThermoFinnigan). Separation of 
the compounds were conducted on an Aquasil, C-18 column (2.1 × 150 mm, 3 μm) 
(Keystone-Hypersil, Bellefonte, PA) using a gradient mobile phase of 0.1% formic acid 
(A) and acetonitrile (B), maintained at a flow rate of 0.2 mL/min. The gradient 
conditions consisted of (A) 80% to 75% in 7 min and maintained for 5 min, followed by 
linear change to 70% in 4 min and finally returned to 80% in 23 min. The mass 
spectrometer was operated using electron spray ionization in negative ion mode (ESI-) 
with the spray voltage set at 3.5 KV.  
 
2.2.4 Quantification by HPLC  
The chemical composition in lemon seed extracts were quantified by HPLC 
(Waters Corporation, Milford, MA) using a reversed phase C-18 Gemini (4.6 mm × 250 
mm, 5 µm) series column (Phenomenex, Torrence, CA) at a flow rate of 1 mL/min, as 
described in our previous publications, with minor modifications (96). The column was 
eluted with a gradient mobile phase of (A) 3 mM phosphoric acid, and (B) acetonitrile. 
The elution of the column was as follows: 85% A - 50% A in 33 min, and 85% A / 15% 
B at the end of 35 min. Limonoids and flavonoids were detected at 210 and 280 nm, 
respectively.  
 
  
  
 
20 
2
0
 
2.2.5 Radical Scavenging Activity 
DPPH Assay 
 Lemon seed extracts were dissolved in MeOH to make a stock solution (5 
mg/ml), and pipetted different concentration (10, 20, 30, and 40 μl) into 96 well plate to 
provide linear concentration profiles. Next, 200 µl of methanolic DPPH (100 µM/L) 
solution was added and the total volume was adjusted to 240 µl by MeOH according to a 
published method (97). The final concentration of actual lemon seed extracts were 
reflected as 208, 417, 624, and 832 µg/ml. Ascorbic acid was used as a positive control 
for comparison. The degradation of the DPPH radical was measured by a KC4 
microplate reader (BioTek Instruments, Winooski, VT) at 517 nm for 30 min.  
ABTS
.+
 Assay 
A solution of ABTS
.+
 was prepared by mixing ABTS (7 mM) and potassium 
persulfate (2.45 mM) in a 1:1 ratio and was then incubated in the dark for 16 h. The 
ABTS radical stock was diluted in MeOH up to 0.7 - 0.75 optical density. Different 
concentrations of lemon seed extracts were pipetted into a 96 well plate, and 200 µl of 
the ABTS solution was added. The degradation kinetics of radical cation (ABTS) was 
monitored by a KC4 microplate reader (BioTek Instruments, Winooski, VT) at 734 nm 
and was recorded every 3 min for 30 min.  
 
2.2.6 Determination of Total Phenolic Content  
The total phenolic concentration was measured using a Folin-Ciocalteu assay 
(98). A standard catechin solution (10, 20, 30, 40, 50, 72, and 100 µg/ml) was prepared 
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in water. Even though hesperidin (HEP), a flavonoid glucoside, is a predominant 
phenolic compound in lemon, it was not selected as a reference compound due to its low 
solubility in an aqueous solution (99). One hundred µL of each extract and different 
concentrations of catechin were pipetted into different tubes. Five hundred µL of Folin-
Ciocalteu (1:1 diluted with water) was added to the tubes, and they were incubated for 
10 min at 25 C. One milliliter of sodium carbonate (7.5% w/v) was added and incubated 
for 30 min. The absorbance was recorded at 765 nm, and results were expressed as 
catechin equivalents (CE). All tests were performed in triplicate and averaged.    
 
2.2.7 Cell Culture  
The MCF-7 cells were cultured in DMEM medium containing 10% fetal bovine 
serum, 200 U/ml penicillin G, and 200 µg/ml streptomycin and incubated at 37 °C with 
5% CO2. The MCF-12F cells were cultured in a 1:1 mixture of DMEM and Ham‟s F12 
medium with 20 ng/ml of epidermal growth factor (EGF), 100 ng/ml cholera toxin, 0.01 
mg/ml insulin, 500 ng/ml hydrocortisone, and 5% chelex-treated horse serum. Dimethyl 
sulfoxide (DMSO) was used to dissolve the lyophilized extracts, and the same 
concentration of DMSO (< 0.2%) was used in the control cell group.  
 
2.2.8 Cytotoxicity Assay 
The cytotoxicity was determined by MTT assay (100). The cells (1 × 10
4
 / well) 
were seeded in a 96 well microplate and cultured in the presence of 0, 12.5, 25, 50, 75, 
and 100 µg/ml of the EtOAc, acetone, MeOH, and MeOH:water (80:20) extracts, and 
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tamoxifen, and then were incubated for 24, 48, and 72 h. The cells were treated with 10 
µL MTT reagents (5 mg/ml) and incubated for 2 h at 37 °C to obtain purple-colored 
formazan. The color was dissolved in 200 µL of DMSO and measured by an ELISA 
microplate reader (BioTek Instruments, Winooski, VT) at 570 nm. All values were 
calculated as a percent of the unviable cell number compared to the control from three 
independent experiments performed in triplicate.  
 
2.2.9 DNA Fragmentation  
MCF-7 cells (1 × 10
6
) were seeded in a 100 mm petri dish and incubated, with 
four extracts of lemon seed and DMSO as controls, for 48 and 72 h at 37 °C. Cells were 
harvested and washed with cold phosphate buffered saline. For DNA extraction, a 
harvested cell pellet was resuspended with an extraction buffer (0.1 M NaCl, 0.01 M 
EDTA, 0.3 M Tris-Cl [pH 7.5], 0.2 M sucrose, 10% sodium dodecyl sulfate [SDS]) and 
incubated for 30 min at 65 °C. The DNA was extracted with a phenol, chloroform, and 
isoamyl alcohol (25:24:1) mixture and centrifuged for 10 min at 1200 rpm. The 
supernatant was transferred to a fresh tube and DNA was precipitated by 3M NaOAc 
(pH 5.7) and 100% ethanol and stored at -20 °C overnight. DNA was eluted in a Tris-
EDTA buffer followed by ethanol precipitation. The extracted DNA was separated in 1.5% 
agarose gel and visualized by ethidium bromide staining under UV light (LAS 4000 
imaging, Fuji Life Sciences, CT).  
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2.2.10 Western Blot 
MCF-7 cells (1 x 10
6
) were treated with the MeOH:water (80:20) extract (100 
μg/ml) and incubated for 24, 48, and 72 h. Total protein was extracted in a lysis buffer 
(150 mM NaCl, 10 mM Tris-Cl [pH 7.2], 0.1% SDS, 1% Triton X-100, 1% 
deoxycholate, and 5 mM EDTA) with a protease inhibitor cocktail (GenDEPOT, TX). 
Cytosolic fractions for cytochrome c detection were prepared using a cell fractionation 
kit (Bio-Vision incorporated, Mountain view, CA) according to the manufacturer‟s 
instructions. Protein concentration was determined by the bicinchoninic acid method 
(Pierce, IL). Thirty µg of protein from each sample was separated by electrophoresis on 
12% SDS-PAGE. The gel was blotted onto a PVDF membrane by semi-dry transfer 
(Bio-Rad, CA). The membranes were blocked with 5% non-fat dry milk in a TBS-T 
buffer (10 mM Tris-Cl [pH 8.0], 100 mM NaCl, and 0.1% Tween 20) for 1 h and then 
incubated overnight with a specific primary antibody such as anti-Bax (1:500), anti-Bcl2 
(1:500), anti-cytochrome c (1:500), anti-β-actin (1:1000), and anti-PARP (1:1000)for 
each protein. Subsequently, the membrane was washed with a TBS-T buffer and was 
probed with a goat anti-mouse IgG-horseradish peroxidase conjugate (1:2000) (Santa 
Cruz Biotechnology, CA). The protein band signal was detected by a 
chemiluminescence (ECL) detection kit (Amersham Bioscience, NJ), and the image of 
the signal was visualized by the LAS 4000 mini-imaging system (Fuji Life Sciences, 
CT).  
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2.2.11 Statistical Analysis  
Statistical significance was analyzed by a Statistical Package for the Social 
Sciences (SPSS) 16.0 software (Chicago, IL) and expressed as means with either 
standard deviation or standard error with P-value. The statistical differences between the 
control and treatment groups were evaluated by one-way analysis of variance (ANOVA), 
followed by both Fisher‟s least significant difference and Turkey‟s multiple comparisons. 
P < 0.05 was considered significant.  
 
2.3 Results and Discussion 
2.3.1 Extraction and Identification of Bioactive Components in Lemon Seed Extracts 
Successive solvent extraction of the lemon seed in a Soxhlet apparatus resulted in 
obtaining a yield of 78.62 g (3.27% w/w), 16.37 g (0.68% w/w), 221.50 g (9.23% w/w), 
and 402.60 g (16.78% w/w) for the EtOAc, acetone, MeOH, and MeOH:water (80:20) 
extracts, respectively. To investigate the effects of lemon seed components on human 
breast cancer (MCF-7) and non-malignant (MCF-12F) cells, all the extract were freeze-
dried, and chemical constituents of lemon seed extracts were identified by LC-MS 
analysis. Our previous studies suggested that limonoids and flavonoids are the main 
bioactives present in citrus (7, 36, 47). Fig. 2.1 represents the molecular ion peaks of 
HEP (m/z 609.53), isolimonexic acid (ILNA) (m/z 501.55), limonexic acid (LNA) (m/z 
501.39), limonin (m/z 469.76), and nomilin (m/z 515.31).  
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LG HEP NAG OG ILNA LNA Limonin Nomilin 
Extracts 
EtOAc - + - + + + + + 
Acetone - + + + + + + + 
MeOH + + + + - - + + 
MeOH:water + + + + - - + + 
 
Fig. 2.1 Identification of bioactive compounds present in the lemon seed extracts by LC-
MS using electron spray ionization (ESI) with negative ion mode. (A) Mass spectra of 
hesperidin and limonoids (B) Identified limonoids in different extracts.  
B 
A 
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Apart from the limonoid aglycones, three glucosides such as limonin glucoside 
(LG) (m/z 649.53), obacunone glucoside (OG) (m/z 633.64) and nomilinic acid 
glucoside (NAG) (m/z 711.64) were identified in the MeOH and MeOH:water (80:20) 
extracts. The molecular ion peaks are in agreement with previous reports (36, 101, 102).  
 
 
2.3.2 Quantification of Bioactive Compounds in Lemon Seed Extracts  
Limonoids and flavonoid based on LC-MS (Fig. 2.1), the compounds were 
quantified by reversed phased HPLC according to our previously established procedure 
(96, 103). Quantified limonoids and hespridin (HEP) from lemon seeds were presented 
in Table 2.1. The successive Soxhlet extraction of lemon seeds using different polar 
solvents enabled in obtaining selective ratio of polar and nonpolar compounds. Among 
the quantified compounds, the concentration of HEP was relatively higher in acetone 
extract (26%) in comparison to the lowest content (3%) in the EtOAc extract. The higher 
amount of limonoid aglycones, limonin (48%) and nomilin (37%) were present in the 
EtOAc extract whereas MeOH:water (80:20) extract which had the lowest levels, 5% 
and 1% respectively. In contrast, the MeOH:water (80:20) extract contained the highest 
level of glucosides (86%) as compared to the other extracts such as EtOAc extract (12%), 
acetone extract (46%), and MeOH extract (75%). Limonin glucoside was detected in 
MeOH and MeOH:water (80:20) extracts. ILNA and LNA were also detected in EtOAc 
and acetone extracts (Fig. 2.1). However, they were lower than the limit of quantification 
(Table 2.1). The failure of quantification for three compounds is due to lower detection 
sensitivity and selectivity of HPLC with UV absorbance than LC-MS (104).    
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Table 2.1 Levels of bioactive compounds (mg/g w/w) present in different lemon seed    
extracts* 
 
 EtOAc  Acetone  MeOH  MeOH:water 
Compounds 
Hesperidin 
 
3.13 ± 0.40 
     (3%) 
16.84 ± 0.00 
      (26%) 
 19.16 ± 0.19 
      (11%) 
 11.13 ± 0.16 
        (8%) 
NAG 
 
        - 
 8.45 ± 0.19 
(13%) 
 56.75 ± 0.53 
 (31%) 
 61.73 ± 0.34 
        (42%) 
OG 
 
11.87 ± 0.06 
       (12%) 
21.02 ± 0.09 
      (33%) 
 79.92 ± 0.07 
       (44%) 
 65.19 ± 0.09 
        (44%) 
Limonin 
 
46.88 ± 0.34 
       (48%) 
12.00 ± 0.14 
      (19%)  
 17.74 ± 0.10 
       (10%) 
   7.52 ± 0.42 
         (5%) 
Nomilin 
 
36.08 ± 0.33 
       (37%) 
6.30 ± 0.15 
    (10%) 
   7.75 ± 0.35 
         (4%) 
   1.28 ± 0.06 
         (1%) 
*Results are average of three independent experiments performed in triplicate. 
 
2.3.3 Radical Scavenging Activity of Lemon Seed Extracts  
ROS generation by up-regulating antioxidant systems is a bona fide method to 
develop anti-cancer agents (105). It is speculated that the inverse correlation between a 
diet rich in fruits and vegetables and cancer incidence is closely connected with the high 
amount of dietary antioxidants (106). Previously, we have demonstrated that citrus fruit 
(citron and blood orange varieties) extracts are a good source of free radical or reactive 
oxygen species scavengers (89). Indeed, the EtOAc and MeOH:water (80:20) extracts 
have demonstrated minimum and maximum antioxidant effects, respectively (Fig. 2.2). 
Lemon seed extracts were treated with DPPH and ABTS
.+
 to quench the free radicals, 
and the reaction was monitored for 30 min at different concentrations. In Fig. 2.2A and 
2.2B, the kinetics graphs represent the degradation rate of free radicals. The capabilities 
of free radical quenching such as DPPH and ABTS
.+
 with lemon seed extracts is directly 
proportional to the radical scavenging activity. The MeOH:water (80:20) extract 
  
 
28 
2
8
 
exhibited the highest radical scavenging activity (62.2% and 91.3%), while the EtOAc 
extract showed the lowest radical scavenging activity (2.4% and 17.3%) at 833 µg/ml in 
the DPPH and ABTS
.+
 assay, respectively (Fig. 2.2C and 2.2D). The radical scavenging 
activity of lemon seed extracts showed in a concentration-dependent manner. The order 
of antioxidant activity was found in MeOH:water (80:20) > MeOH > acetone > EtOAc 
(Fig. 2.2C and 2.2D).   
 
 
 
Fig. 2.2 Radical scavenging activity of various solvent extracts and ascorbic acid was 
measured as kinetic change of (A) DPPH radical and (B) ABTS
.+
. The value was 
monitored for every 3 min at a 208 µg/ml concentration. Values were expressed means 
of three independent experiments with standard deviation. 
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Generally, phenolic compounds are significant contributors of the antioxidant 
activities of fruit and vegetables. Thus, total phenolic content of the four extracts were 
determined by Folin-Ciocalteu method. The maximum (7.2 mg CE/g) and minimum (4.7 
mg CE/g) phenolic content was observed in the MeOH:water (80:20) and the EtOAc 
extract, respectively (Fig. 2.3). According to Bocco et al. (107), the total content of six 
different glycosylated flavanones in the lemon seed MeOH extract was 2.15 mg/g by 
HPLC analysis. In the present study, MeOH extract has 5 mg CE/g total phenolics by 
Folin-Ciocalteu method. Higher levels of total phenolics determined in Folin-Ciocalteu 
method is not absolute measurements of the amounts of phenolic compounds, but are in 
fact based on their chemical reducing capacity relative to CE.  
Comparison of present data and previous reports is difficult since there is no data 
on phenolic content of lemon seed. Sun et al. (108) found that the total phenolic content 
(0.81 ± 0.03 mg/g fresh fruit) and total antioxidant activity (42.8 ± 1.0 μM/g) of lemon 
extract were directly correlated with each other. Similar correlation results were 
observed in present investigation of lemon seed extracts (Fig. 2.2 and 2.3) (109). In the 
EtOAc extract, limonoid aglycones were determined as major constituents (Fig. 2.1 and 
Table 2.1). Since limonoids were inactive as a radical scavenger (110), it is possible that 
the lowest radical scavenger activity of the EtOAc extract is due to the presence of 
limonoid (Fig. 2.2 and 2.3). On the other hand, the MeOH and MeOH:water (80:20) 
mixture were used to elute polar compounds including limonoid glucosides and 
flavonoid glucoside. The higher antioxidant capacity of the methanolic extract may be 
due to the presence of flavonoid and polar compounds.  
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Fig. 2.3 Total phenolic content present in different lemon seed extracts. Values are 
expressed means of three independent experiments with standard deviation. 
 
2.3.4 Effect of Different Extracts on Cytotoxicity  
To evaluate the cytotoxicity of extracts, breast cancer (MCF-7) and non-
malignant (MCF-12F) cells were treated with four lemon seed extracts and their 
proliferative ability was examined by MTT assay. Among the four extracts, EtOAc and 
MeOH:water (80:20) extracts exhibited 24% (P < 0.01) and 29.1% (P < 0.01) inhibition 
of MCF-7 cell growth respectively, at 100 µg/ml for 48 and 72 h. This inhibition was 
time- and concentration-dependent (Fig. 2.4) whereas acetone and MeOH extracts 
showed significant growth inhibition at 72 h for 100 µg/ml concentration. However, 
tamoxifen significantly inhibited breast cancer cells at all the tested concentrations and 
time (Fig. 2.4). Limonoids have been reported as potent inhibitor compared to hesperidin 
in MCF-7 cells (16, 111). In this study, the activity of EtOAc was directly proportional 
to the content of limonoids (Table 2.1). Tian et al. (16) reported that the mixture of 
limonoid glucosides (IC50 = 0.013 mM) was more potent than a single limonoid in the 
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anti-proliferative activity on MCF-7 cells. Indeed, these results suggest that higher 
cytotoxicity of the methanolic extracts may be due to the presence of limonoid aglycones, 
limonoid glucosides, and hesperidin (Fig. 2.1 and Table 2.1). Additionally, the presence 
of higher amount of phenolics could be relevant to the highest cytotoxicity of 
MeOH:water (80:20) extracts. Treatment with the same concentration of all extracts for 
72 h did not show cytotoxicity in MCF-12F non-malignant cells. Tamoxifen was used as 
a positive control and significantly inhibited non-malignant breast cancer cells (MCF-
12F) at all the tested concentrations and time (Fig. 2.4).  
 
2.3.5 Apoptotic Phenotypes of MCF-7 Cells by Lemon Seed Extracts  
One of the best-studied biochemical characteristics of apoptosis is 
internucleosomal DNA cleavage, which generates a characteristic DNA ladder (80). To 
investigate whether the inhibitory effect on MCF-7 cell proliferation was associated with 
the activation of apoptosis, a DNA fragmentation assay was conducted with the different 
extracts. As predicted from the antioxidant and anti-proliferative activity, the 
MeOH:water (80:20) extract induced DNA fragmentation at 75 and 100 µg/ml for 48 
and 72 h (Fig. 2.5C). 
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          Human breast cancer                                    Human breast non-malignant 
          MCF-7 cells                                                    MCF-12F cells 
 
 
Fig. 2.4 Proliferation inhibition of human breast cancer cells (left panels) and non-
malignant cells (right panels) by different lemon seed extracts was determined by the 
MTT assay. Cells (1 x 10
4 
/ well) were incubated with either each extract or tamoxifen at 
0, 12.5, 25, 50, 75, and 100 µg/ml at different time points. The data are expressed as the 
percent of cell inhibition. The bars represent standard errors. (*P < 0.05, **P < 0.01) 
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In addition, the MeOH extract also induced the DNA fragmentation (Fig. 2.5B). 
However, the EtOAc and acetone extracts did not show the laddering patterns (Fig. 
2.5A). This may be due to the high content of limonoid glucosides in the methanolic 
extracts. The order of total limonoid glucosides content was found in MeOH:water 
(80:20) extract (86%) > MeOH extract (75%) > acetone extract (46%) > EtOAc extract 
(12%) (Table 2.1).  
Even though the EtOAc and acetone extracts did not show DNA fragmentation, 
both these extracts showed anti-proliferative activity at 100 µg/ml for 72 h. In our 
previous study, induction of G1 cell cycle arrest was demonstrated in human colon 
cancer cells by ILNA and sitosterol glucoside (52). Accordingly, the current study 
strongly supports that limonoid aglycones mainly present in EtOAc extract may induce 
cell cycle arrest.  
Bcl-2 family proteins were demonstrated to cause apoptosis by up-regulation of 
pro-apoptotic protein (Bax) and down-regulation of anti-apoptotic protein (Bcl2, bcl-
XL), leading to cytochrome C release from mitochondria and its complex with the Apaf-
1 (apoptotic protease activating factor-1) activate downstream caspase cascade (caspase 
-8,-9,-3,-6,-7), as well as PARP cleavage (82, 112). Since MeOH:water (80:20) extracts 
showed the highest anti-proliferative activity in a time- and concentration-dependent 
manner, we used the MeOH:water (80:20) extract to understand the upstream 
mechanism of DNA fragmentation in MCF-7 cells. 
As shown in Fig. 2.5D, Bax and cytosolic cytochrome C protein expression was 
up-regulated, and Bcl2 protein expression was down-regulated for 72 h using the 
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MeOH:water (80:20) extract. The increased cytochrome c in the cytosolic fraction (Fig. 
5D) is enough to support inducing apoptosis. Similar results were published recently 
from our group (113) and others (114).  
 
 
 
Fig. 2.5 The apoptotic features of lemon seed extracts. MCF-7 cells were treated with 
(A) EtOAc and acetone, (B) MeOH, and (C) MeOH:water (80:20) extracts and 
harvested after 48 and 72 h. The DNA fragmentation was assayed by 1.5% agarose gel 
electrophoresis in a TBE buffer. M (Marker). (D) The cells were treated with 
MeOH:water (80:20) extracts (100 µg/ml) for 24, 48, and 72 h and detected with a 
represented antibody by immunoblotting. β-actin levels served as a protein loading 
control. Protein was separated on 8-12% SDS-PAGE gel.  
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In addition, cleaved PARP was enhanced by the MeOH:water (80:20) extract, 
and these results are consistent with the DNA fragmentation in Fig. 2.5C. β-actin was 
used as an internal control. These results clearly demonstrated that the MeOH:water 
(80:20) extract induced apoptotic responses such as increased pro-apoptotic Bax, 
decreased anti-apoptotic Bcl2, released cytochrome C, and cleaved PARP in MCF-7 
cells (Fig. 2.5C and 2.5D). Finally, it is possible that the solubilized bioactive 
compounds in the MeOH:water (80:20) extract may activate apoptosis in the MCF-7 
cells at the cellular level.  
Although the EtOAc extract has a significant amount of limonoid aglycones such 
as limonin, and nomilin, the anti-cancer activity is low as compared to MeOH:water 
(80:20) extract. It could be speculated that the concrete effect of the highest antioxidant 
and anti-cancer activity of the MeOH:water (80:20) extract from lemon seed may be due 
to the presence of higher amount of limonoid glucosides such as OG and NAG (Table 
2.1).  
 
2.4 Conclusion 
Bioactive components in lemon seed extracts could be a good source of 
antioxidants and induce apoptosis in MCF-7 breast cancer cells through the 
mitochondrial apoptosis pathway attributed from the increased Bax, decreased Bcl2, 
released cytochrome C in cytosol, and cleaved PARP. Moreover, this research 
demonstrated for the first time that lemon bioactive compounds are non-toxic to non-
malignant breast cells. Future studies should aim to purify and identify compounds 
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present in MeOH:water (80:20) extracts and understand their mechanism of apoptosis 
induction. These findings support the hypothesis that bioactive compounds from lemon 
may have cancer-preventive properties.   
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3. SCREENING OF LIMONOIDS FOR ANTI-PROLIFERATIVE ACTIVITY IN 
HUMAN BREAST CANCER CELLS 
 
3.1 Introduction 
Using different identification techniques, 62 limonoids have been identified and 
there is an ongoing effort to discover even more (9, 52). In 1949, a study was conducted 
to investigate the bitterness of citrus fruit (9). Later, the medicinal potential of limonoids 
on human health became newsworthy when their anti-tumor properties for leukemia 
cells were discovered in 1983 (115). It was later found that these cancer fighting 
properties could be extended to other type of human cancers such as colon (HT-29 and 
SW480) (50, 52, 116, 117), pancreatic (Panc-28) (36, 55, 118), leukemia (MOLT-4 and 
P388) (115, 119), breast (MCF-7 and MDA-MB-435) (16, 53), liver (HepG2) (41) and 
neuroblastoma (SH-SY5Y) (51, 54). Besides the anti-tumor properties, it may also be 
useful in prevention of coronary heart disease and inflammation (50, 120). Nevertheless, 
only two studies have been conducted to investigate the anti-proliferative effect of 
limonoids on estrogen receptor negative (ER-) and estrogen receptor positive (ER+) 
MCF-7 cell lines (16, 53). However, the cancer inhibition mechanism by limonoids in 
breast cancer remains to be investigated.   
Patil‟s group has been investigating the potential health benefits of citrus 
bioactive compounds for improving human health (16, 50-52, 54, 55, 116-118, 120). 
Unfortunately, the limonoids are not commercially available except nomilin and limonin. 
It is imperative that limonoids be purified in order to test their efficacy in vitro as well as 
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in biological tests such as animal experimentation and clinical trials. Previously, Patil‟s 
group have reported efficient purification methods of diverse citrus species from sour 
orange to grapefruit using different analytical techniques such as liquid 
chromatography/electrospray ionization/ mass spectrometry (LC-ESI-MS), flash 
chromatography, column chromatography, and supercritical CO2 extraction (89, 102, 
121, 122). Even though lemon is in the top three most popular citrus fruit followed by 
orange and grapefruit, an importance of lemon as potential source of limonoids have not 
been yet evaluated.   
Hormone sensitivity has been found to be one of the key signatures in breast 
cancer diagnosis (73). More than 60% of breast tumors exacerbated by excessive 
estrogen and the presence of estrogen receptors (ER) result in better prognosis than ER-
negative (74). Although the ER positive breast tumors are more responsive to 
chemotherapy than negative breast tumors, the outcome of anti-cancer agents are not 
always followed by same mechanism due to the complex interaction of anti-cancer and 
human disease.          
In this context, we aimed to purify different limonoids from lemon byproducts, 
particularly the seeds, and confirm their identity by using HPLC and mass spectra. 
Further, the purified limonoids were screened for potential biological activity in both 
ER-positive and ER-negative human breast cancer cells. Moreover, we further 
investigated the possible mechanism underlying the inhibition of human breast cancer 
cell proliferation by limonoids.   
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3.2 Materials and Methods 
3.2.1 Materials 
All solvents used for isolation and analysis were HPLC grade (EDM Chemical 
Inc., Gibbstown, NJ). TLC silica gel 60F-254 plate and silica gel (200-400 mesh) were 
obtained from Fisher Chemicals (Fair Lawn, NJ). Dowex-50 and Diaion HP-20SS resin 
were supplied from Supelco Incorporation (Bellefonte, PA). The ER-positive (MCF-7) 
and ER-negative (MDA-MB-231) human breast cancer cell lines were purchased from 
the American Type Culture Collection (ATCC) (Manassas, VA). Other chemicals and 
biochemical materials were purchased with highest available purity.  
 
3.2.2 Extraction and Isolation 
Dried lemon seeds (14 kg) were powdered and defatted with hexane using 
Soxhlet apparatus for 16 h. The defatted powder was sequentially extracted with 6 L of 
ethyl acetate (EtOAc), acetone, methanol (MeOH), and MeOH:water (80:20) (v/v) for 
16 h each, successively. The EtOAc and MeOH concentrated extracts were obtained by a 
rotary evaporator (Büchi, Switzerland) under a vacuum. The dried EtOAc extract was 
placed onto a silica gel 60 (particle size 40-63 micron) column and mobile phases such 
as hexane, chloroform, acetone, and methanol with increasing polarity was injected into 
the column. Each fraction (1000 ml) was collected in a test tube and allowed to dry to 
achieve compound crystallization. Compound 1, 2, and 3 were eluted and crystalized 
with hexane: chloroform (50:50 (v/v), 25:75 (v/v), and 10:90 (v/v), respectively), while 
compounds 4 and 5 were crystallized in chloroform: acetone (80:20) (v/v) fractions. 
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Interestingly, after the elution of compound 4, compound 5 began to elute in the same 
mobile phase.  
The MeOH and MeOH:water extracts were loaded to activated Dowex-50 (H
+
) 
column connected with the SP-70 column. Then, the absorbed limonoids in the SP-70 
column were eluted with linear gradient mobile phases consisting of acetonitrile (ACN) 
in water (v/v) according to previously published procedure (89). Compound 6 was eluted 
with 12.5% ACN in water. The 20- 25% ACN in water fractions were analyzed by 
HPLC and then pooled based on the retention time. The fractions with similar retention 
time were loaded onto the Diaion HP-20SS (Supelco, PA) cross-column and separated 
with mobile phases consisting of ACN in water (v/v). Compound 7 was eluted only with 
water. Compounds 8 and 9 were eluted with 5% (v/v) and 22.5% (v/v) ACN in water, 
respectively.  
 
3.2.3 Preparation of Defuran Nomilin and Defuran Limonin 
The modified compounds such as limonin methoxime (LM) and limonin oxime 
(LO) were prepared according to our previously established procedures (47, 120).             
Defuran nomilin was prepared as follows, nomilin (0.514 g) acetonitrile (20 ml), carbon 
tetrachloride (10 ml), and water (15 ml) were mixed in a 100 ml round-bottom flask, and 
the reaction mixture was kept for stirring at room temperature for 10 min. Sodium 
periodate (4 g) and ruthenium trichloride (100 mg) were added, and stirring was 
continued until the completion of the reaction (∼40 h). The reaction was monitored by 
thin layer chromatography. The reaction mixture was extracted with ethyl acetate in a 
  
 
41 
4
1
 
separating funnel, decolorized using activated charcoal, filtered, and concentrated under 
vacuum. The dried residue was extracted with chloroform and crystallized to obtain 
defuran nomilin (108 mg), while defuran limonin was prepared from limonin according 
to Perez et al (47).  
 
3.2.4 Identification using HPLC/ LC-MS/NMR 
All fractions were analyzed by thin layer chromatograph. The purified limonoids 
were identified with HPLC, LC-MS, and NMR spectra (58, 89, 120, 123). HPLC 
analysis was carried out using a Perkin Elmer instrument with diode array detector 235C 
using C18 reversed-phase Gemini column (4.6 mm × 250 mm, 5 µm, Phenomenex, CA). 
Compound 1-9 were detected at 210 nm. The mobile phase consisted of (a) 3 mM 
phosphoric acid, and (b) acetonitrile at a flow rate of 1 ml/min, as described previously 
(96).  
Mass spectra of compounds were analyzed using an API QSTAR Pulsar Hybrid 
QTOF instrument (Applied Biosystems/MDS Sciex, Framingham, MA). The structure of 
purified compounds was identified by 
1
H and 
13
C NMR. The NMR spectra were 
recorded on a JEOL ECS-400 spectrometer using tetramethyl silane as the internal 
standard. The purified limonoids were dissolved in DMSO and chloroform, and analyses 
were conducted at 25 ºC. The spectra was recorded using a 5 mm broadband probe 
equipped with a shielded z-gradient and Delta software version 4.3.6. Tetramethylsilane 
was used as an internal reference. 
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3.2.5 Cell Culture 
The MCF-7 cells were grown in a DMEM medium supplemented with 10% (v/v) 
fetal bovine serum (FBS), 2 mM L-glutamine, 200 units/ml penicillin G, and 200 µg/ml 
streptomycin. The MDA-MB-231 cells were cultured with the DMEM medium 
supplemented with 10% (v/v) FBS, 1% (v/v) sodium pyruvate, 1% (v/v) non-essential 
amino acids, 2 mM L-glutamine, 200 units/ml penicillin G, and 200 µg/ml streptomycin. 
Both cell lines were incubated at 37°C with 5% CO2.    
 
3.2.6 Cytotoxicity Assay 
The cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction assay. In brief, both breast cancer cell 
lines were seeded (1 × 10
4 
cells/well) in 96 well plates and incubated overnight to allow 
the cells to attach. To test the cytotoxic effect of limonoids, the limonoids were 
dissolved in DMSO and the dissolved limonoids (200 μM) were incubated with either 
MCF-7 or MDA-MB-231 cells for 72 h. At the end of the incubation period, 10 μl of 
MTT reagent (5mg/ml) was added to each well and exposed for another two hours. 
During this incubation period, viable cells convert tetrazolium salt to purple formazan 
due to mitochondrial dehydrogenase activity (124). After the two hour incubation period, 
the absorption of dissolved formazan using DMSO was read at 570 nm on a KC4 
microplate reader (BioTek Instruments, Winooski, VT). All experiments were performed 
in triplicate three times. The MTT reduction was calculated as follows: (A of 
experimental group / A of control group) × 100.   
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3.2.7 Aromatase Activity Assay 
In vitro aromatase inhibition assay was performed using CYP19/ Methoxy-4-
trifluoromethyl-coumarin (MCF) high-throughput screening kit (BD Biosciences, 
Woburn, MA) following the manufacturer‟s protocol. Briefly, the tested limonoids were 
dissolved in acetonitrile. Various concentrations of limonoids were placed into 96-well 
black microtiter plates (BD Falcon
TM
) and pre-incubated with NADPH-Cofactor mixture 
(8.1 μM NADP+, 0.4 mM MgCl2, 0.4 mM glucose-6-phosphate, 0.2 U/ ml glucose-6-
phosphate dehydrogenase) for 10 min at 37 °C. After adding an enzyme and substrate 
(25 μM MFC and 1.5 pmol/well CYP19), the reactions were allowed for 30 min at 37 
°C. The fluorescence was measured at 405 nm (excitation) and at 530 nm (emission). 
Ketoconazole was used as a positive control. Experiments were carried out on two 
separate occasions. 
 
3.2.8 Western Blot 
Whole cell lysates were prepared, as described previously (120). The protein 
concentration was measured using the BCA method. The same concentration (25 μg) of 
protein was subjected to 8% (PARP) or 12% (caspase-7) SDS-PAGE and transferred 
onto a PVDF membrane (Bio-Rad, Hercules, CA). The blots were proved with the 
polyclonal rabbit poly (ADP-ribosyl)polymerase (PARP) (1:1000), polyclonal rabbit 
caspase-7 (1:1000) antibody (Cell Signaling Technology, Beverly, MA) and monoclonal 
beta-actin (1:1000) antibody (Santa Cruz Biotechnology). Secondary horseradish 
peroxidase-labeled antibodies (1:2000) were evaluated under enhanced 
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chemiluminescence. The intensity of band signals was quantified by LAS 4000 mini 
(FUJI Film, Tokyo, Japan). The data were expressed as means ± standard error (S.E.) 
from three independent experiments.  
 
3.2.9 Statistical Analysis 
The statistical significance of the data was evaluated by one-way analysis of 
variance followed by Fisher‟s Least Significant Difference using the SPSS 16.0 program 
(Chicago, IL). Pearson's correlation was performed to evaluate the degree of correlation 
of the effects of limonoids between proliferations versus aromatase inhibition, aromatase 
inhibition versus caspase-7, and proliferation versus caspase-7. The P value (for two-
tailed) was considered to be significant within 95% confidence intervals. 
 
3.3 Results  
3.3.1 Purification and Identification of Limonoids 
Five aglycones (1-5) and four glucosides (6-9) were isolated from EtOAc and 
MeOH extracts, respectively. The chemical composition was analyzed by TLC and 
reversed phase HPLC. The compounds (1-5) were observed at retention time 43.7, 52.3, 
41.4, 21.3, and 22.4 min, respectively. Compounds (6-9) were observed at retention time 
19.49, 21.66, 34.61, and 36.12 min, respectively. Yield of compounds (1-9) were 4.0, 
0.07, 16.0, 0.35, 0.98, 4.8, 0.12, 2.7, and 4.5 g, respectively. The mass spectra of 
compounds (1-9) were confirmed and matched to our previously reported value (58, 89, 
123). Based on the HPLC and mass spectra data, compounds 1-9 were identified and 
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characterized as nomilin, obacunone, limonin, limonexic acid (LNA), isolimonexic acid 
(ILNA), limonin glucoside (LG), deacetyl nomilinic acid (DNAG), nomilinc acid 
(NAG), and obacunone glucoside (OG), respectively. The structures of purified 
limonoids were presented in Fig. 3.1. 
 
 
Fig. 3.1 The structure of purified limonoids from lemon seeds. 
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3.3.2 Modification of Limonoids  
Defuran nomilin was prepared from nomilin by oxidative cleavage of furan ring 
at C20 position. The oxidation reaction was performed at 25 C using ruthenium 
trichloride-sodium periodate in the presence of CCl4-CH3CN-H2O (2:2:3) solvent 
system (125) to obtain defuran nomilin. Fig. 3.2 depicts a complete assignment of 
1
H 
and 
13
C NMR signals of defuran nomilin, which was recorded in CD3OD. Proton spectra 
was quite complex specifically in the region between 1 and 3 ppm.   
 
 
Fig. 3.2 
1
H and 
13
C NMR spectra of defuran nomilin recorded using JEOL ECS 
spectrometer at 400 and 100 MHz respectively. Solvent used for NMR recording was 
CD3OD and marked with asterisks. Assignments of all protons and carbons were made 
on the respective spectrum.   
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Six sharp single peaks for 3H with a characteristic chemical shifts and intensity 
between 1 and 2.1 ppm have been assigned to methyl groups. It is clear from the 
1
H 
spectra that there are no aromatic signals at 6 to 8 ppm for the furan ring, which is 
further confirmed in 
13
C spectra. An additional carbonyl signal at 168.5 ppm was 
assigned to carboxylic group at C20 position. The rest of the chemical shifts shown in 
Fig. 3.2 was matched to our previously reported values for nomilin (123). 
 
3.3.3 Cytotoxicity of Limonoids in MCF-7 and MDA-MB-231 
To evaluate the cytotoxic effect of limonoids, MTT reduction by tamoxifen (as a 
positive control), purified limonoids, and modified limonoids were measured as shown 
in Fig. 3.3. The MCF-7 cell lines were more susceptible than MDA-MB-231 to almost 
all the tested limonoids except the LG. Among 13 limonoids, six limonoids (limonin, 
DNAG, obacunone, OG, NAG, LO, and DN) showed significant cytotoxicity from both 
MCF-7 and the MDA-MB-231 cell. Notably, the obacunone exhibited the highest 
cytotoxicity of 44% (P < 0.01) and 18% (P < 0.01) in MCF-7 and MDA-MB-231 cells, 
respectively. However, no cytotoxicity was detected by LNA and DL in either cell lines.  
The limonin (21%, P < 0.01 and 19%, P < 0.01) and its modified forms, such as 
LM (30%, P < 0.01 and null) and LO (23%, P < 0.01 and 17%, P < 0.01), exhibited 
significant cytotoxic effect in MFC-7 and MDA-MB-231, respectively, but the 
modification of limonoids did not show any significant effect on the cytotoxicity 
compared to the parent limonoid; whereas defuran limonin lost the cytotoxicity in both 
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cell lines. In contrast, defuran nomilin showed significant cytotoxicity 20% (P < 0.05) 
and 9% (P < 0.01) in MFC-7 and MDA-MB-231, respectively.    
 
 
Fig. 3.3 Cytotoxic effect of purified or modified limonoids in human breast cancer cells.  
ER-positive breast cancer (MCF-7) or ER-negative breast cancer (MDA-MB-231) cells 
were treated with either DMSO (vehicle) or indicated limonoids (200 μM) for 72 h. 
After the 72 h incubation, the cytotoxic effect was determined by MTT assay. The bar 
represents means ± S.M.E. (n = 9-12). (* P < 0.05, ** P < 0.01) 
     
3.3.4 Inhibition of Aromatase Activity by Limonoids 
To determine if the susceptibility of MCF-7 for cytotoxicity by limonoids was 
due to estrogen receptor, aromatase activity was evaluated using CYP19 high throughput 
inhibition assay, shown in Table 3.1. The majority of limonoids were significantly 
inhibited the catalytic activity of aromatase enzyme except LNA (Table 3.1). Among 13 
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limonoids, LG and obacunone exhibited the most and least potent aromatase inhibition 
activity with an IC50 value of 1.27 μM (P < 0.001) and 28.04 (P < 0.05), respectively. 
 
 Table 3.1 IC50 for inhibition of aromatase by limonoids   
 
Test compounds IC50 (μmol/L) P-value 
Ketoconazole (positive control)   0.85 0.000 
Limonin   5.22 0.026 
Limonexic acid (LNA) 20.02 0.344 
Deacetyl nomilinic acid glucoside (DNAG)   4.41 0.008 
Isolimonexic acid (ILNA) 25.60 0.034 
Nomilin 18.86 0.000 
Obacunone 28.04 0.024 
Limonin glucoside (LG)   1.27 0.000 
Obacunone glucoside (OG) 26.37 0.000 
Nomilinic acid glucoside (NAG) 11.69 0.008 
Limonin methoxime (LM)   1.65 0.000 
Limonin oxime (LO)   2.00 0.000 
Defuran limonin (DL)   1.65 0.000 
Defuran nomilin (DN)   3.04 0.000 
 
 
3.3.5 Effect of Limonoids on Activation of Caspase-7  
Whether the cytotoxicity influences the caspase-7 activity in the presence of 
limonoids in MCF-7 was investigated using immunoblotting. As shown in Fig. 3.4, 
obacunone treated MCF-7 cells exhibited a 3.6-fold (P < 0.01) activation of caspase-7 
followed by LG (2.8-fold, P < 0.05) while the effect of nomilin (2.4-fold, P < 0.08) and 
OG (2.4-fold, P < 0.09) on activation of caspase-7 was less significant.  
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Fig. 3.4 Level of activated caspase-7 by different limonoids on ER-positive breast 
cancer cells. The MCF-7 cells were treated with limonoids for 72 h and the harvested 
cells were subjected to immunoblotting. Histograms shows the intensity of the 
chemiluminescent of activated caspase-7. The values were normalized by full length 
caspase-7. The bar indicates means ± S.E. from five independent experiments. The 
statistical significance of data was demonstrated with P value (* P < 0.05 ** P < 0.01). 
The representative immunoblot was probed with a specific caspase-7 antibody, as 
explained in Materials and methods.     
 
 
 
3.3.6 Correlation Coefficients between the Biological Responses of Limonoids 
To determine the correlation between the responses of limonoids on MCF-7 
cells, the correlation between aromatase inhibition activity and proliferation inhibition 
activity by limonoids was measured by Pearson's correlation coefficient. As shown in 
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Fig. 3.5A. There were no significant correlations between aromatase inhibition and anti-
proliferative activity by limonoids (r = 0.24, P = 0.43). Pearson's correlation coefficients 
indicated that the aromatase inhibition by limonoids tended to be associated with the 
activation of caspase-7 (r = 0.50, P = 0.08) (Fig. 3.5B). In contrast, the activation of 
caspase-7 showed significant positive association with anti-proliferative activity by 
limonoids in MCF-7 cells (r = 0.66, P = 0.02) (Fig. 3.5C).        
        
 
 
 
Fig. 3.5 Interactions between the tested biological reaction of limonoids in ER-positive 
breast cancer (MCF-7) cells. The correlation was determined by Pearson‟s coefficient of 
correlation method (two-tailed). (A) Correlation coefficient between aromatase 
inhibition and proliferation inhibition by limonoids (r = 0.24, P = 0.43), (B) Correlation 
coefficient between caspase-7 activation and aromatase inhibition by limonoids (r = 
0.50, P = 0.08 (marginal significance)), and (C) Correlation coefficient between caspase-
7 activation and proliferation inhibition by limonoids (r = 0.66, P = 0.02). 
 
3.4 Discussion 
The Food and Drug Administration has reported role of natural products (> 50%) 
as anti-cancer treatments (126). Among potential natural products, limonoids, 
abundantly present in citrus fruits, have been touted as one of the most promising anti-
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cancer agent (6, 8, 9). Previous reports from Patil‟s lab and others using multiple 
experimental approaches demonstrated that limonoids have the potential risk reduction 
in many types of cancer such as colon (50, 52, 117), breast (16, 53), pancreatic (36, 55, 
118), leukemia (115, 119), and neuroblastoma (51, 54).        
This study demonstrated the importance of lemon seeds as a source of limonoids. 
Also, results demonstrated that the cytotoxic effect of limonoids from citrus is dependent 
on caspase-7 activation and is more susceptible to ER-positive MCF-7 than ER-negative 
MDA-MB-231 human breast cancer cells. However, even though limonoids exhibited 
anti-aromatase activity, sensitivity of MCF-7 to cytotoxicity by limonoids was 
independent of aromatase inhibition activity.   
Due to the different biological profiles of MCF-7 (containing wild-type p53 gene 
and estrogen receptors) and MDA-MB-231 (containing mutant p53 gene and estrogen 
receptors) (127), the two cell lines are often selected for research as anti-cancer agents 
targeting breast cancer. Generally, the MCF-7 cell lines are more responsive to cancer 
therapy than the MDA-MB-231 cell lines, which have less sensitivity as a result of the 
p53 and ER mutation. In addition, recent papers have indicated that many anti-cancer 
agents were not occur apoptosis in MDA-MB-231 cell lines (127, 128). Similar results 
were obtained from present data that the cytotoxic effect of limonoids was stronger in 
MCF-7 cells than MDA-MB-231 cells. Moreover, these results are consistent with 
previous reports that the resveratrol and genistein, well known anti-cancer agents, are 
known to induce apoptosis in MCF-7 but not in MDA-MB-231 cells (128, 129).    
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Evidences demonstrated that breast tumors are ascribed to estrogen abundance 
(127) and limonoids have shown anti-proliferative activity in MCF-7 cells (Fig. 3.3). 
The aromatase enzyme is responsible for conversion from androgen to estrogen (130), so 
it was reasonable to investigate whether the limonoids have shown the anti-aromatase 
activity for the observed anti-proliferation activity. These results presented that 
limonoids have significant anti-aromatase properties (Table. 3.1). However, the anti-
proliferation by limonoids was not associated with anti-aromatase activity (Fig. 3.5A). It 
should be noted that the aromatase activity is regulated by cyclooxygenase-2 (COX-2) 
suggesting the possible involvement of limonoids in regulation of inflammatory 
signaling pathways (131). Indeed, Patil‟s group previously demonstrated that certain 
limonoids (limonin and obacunone) have shown inhibition of COX-2, inducible nitric 
oxide synthase, and nuclear factor-kappa B translocation in in vitro and in vivo (50, 55). 
Caspases, a member of the cysteine protease family, are the key mediators in cell 
death and the activation of effector caspases such as caspase-7 and caspase-3. These 
caspases are considered a last step of apoptosis (112). However, the caspase-3 is non-
functional in MCF-7 cell lines due to deletion of exon 3 (132), therefore, it was 
important to determine whether caspase-7 is involved in the anti-proliferative activity of 
limonoids. Present data showed a significant positive correlation between the level of 
caspase-7 activation and cytotoxicity induction by limonoids (Fig. 3.5C). In addition, the 
correlation coefficient analysis between the caspase-7 activity and anti-aromatase 
activity exited marginal significant association indicating that the limonoids‟ role as an 
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aromatase inhibitor which cannot be disregarded for potential breast cancer prevention 
(Fig. 3.5B).  
  In conclusion, these results, for the first time, demonstrated that the anti-
proliferative properties of limonoids are mediated by caspase-7 dependent pathways. In 
addition, the cytotoxic effect was more susceptible to estrogen responsive breast cancer 
cells. Also, we found for the first time that the caspase-7 activation showed a trend 
toward improvement of aromatase inhibitory activity of limonoids. Although there was 
no direct correlation between anti-aromatase activity and anti-proliferative activity, the 
potential association between limonoids and estrogen for breast cancer prevention needs 
to be investigated in the future.  
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4. OBACUNONE EXHIBITS ANTI-PROLIFERATIVE AND ANTI-
AROMATASE ACTIVITY IN VITRO BY INHIBITING THE P38 MARK 
SIGNALING PATHWAY IN MCF-7 HUMAN BREAST CANCER CELLS 
 
 
4.1 Introduction 
Despite advances in novel therapeutic agents, breast cancer still remains the 
second leading cause of cancer-related death in women in the United States (133). Since 
about two-thirds of breast cancer patients are considered to have estrogen-receptor (ER)-
dependent tumors (74), most patients are treated with hormone therapy, using drugs such 
as tamoxifen (an ER antagonist) and aromatase inhibitors, which block estrogen activity 
(76). However, concerns about the safety and effectiveness of hormone therapy still exist 
due to both the known and unknown side effects. Plant-based foods have been reported 
to have preventive and treatment-related potential in the clinical applications targeting 
cancer, heart disease, and other human disorders (134, 135). Therefore, numerous 
reports have focused on the identifying agents that naturally occur in plant products and 
can regulate the biological pathway to reduce risk from certain types of cancer.  
Cancer prevention researchers have intensely studied the biological role of 
limonoids in cancer prevention. In animal models, limonoids (limonin, nomilin, and 
obacunone) have inhibited the formation of aberrant crypt foci in azoxymethane-induced 
colon cancer (49, 50). Although the suppression of cell growth has been observed in 
diverse types of cancer cells, little is known about the exact mechanism of inhibition in 
cancer disease. DNA damage or cell cycle regulation error results in apoptosis, which 
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has typical features of morphological changes and a highly conserved biological process 
including stress responses and inflammatory processes. The pro-inflammatory stimuli 
activate the numerous intracellular signaling pathways, such as mitogen-activated 
protein kinases (MAPKs) (67). The MAPKs are composed of extracellular signal-related 
kinases (ERKs), c-Jun N-terminal kinases (c-JNKs), and p38 kinases and play a 
convergent role as a signal transduction mediator, including nuclear transcription factor-
kappa B (NF-κB),  cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase 
(iNOS), in the regulation of cancer processes (67, 136). Consequently, the NF-κB is 
known to regulate the anti-apoptotic proteins such as Bcl-2, cycliin D1, and cyclin-
dependent kinases (CDKs) as well as COX-2 expression (137, 138). Overexpression of 
COX-2 has been reported in malignant tumors, and the positive correlation between 
aromatase and COX-2 has been reported in breast tumors in several in vitro and in vivo 
studies (73, 131). Therefore, an approach to inhibit the aromatase enzyme by 
suppressing COX-2 is considered promising to reduce risk of breast cancer.  
Our previous studies and elsewhere have proved that limonoids inhibit cell 
proliferation in human colon adenocarcinoma (SW-480 and HT-29) (7, 50, 139), 
pancreatic cancer (Panc-28) (36, 55, 140), neuroblastoma (SH-SY5Y) (51, 54), and ER-
independent (MDA-MB-435) (53) and ER-dependent (MCF-7) breast cancer cells (16, 
53). Additionally, obacunone was reported as a glutathione S-transferase (GST) enzyme 
inducer as well as a neuroprotective agent by induction of heme oxygenase-1 via the p38 
MAPK pathway (49, 141). The anti-proliferation and anti-inflammatory activity of 
obacunone was also reported in pancreatic and colon cancer cell (55, 116). However, the 
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regulatory mechanisms of obacunone in anti-inflammation and pro-apoptosis in breast 
cancer are unknown. To evaluate the role of obacunone as potent anti-cancer agent, in 
the present study, we investigated the effect on anti-proliferation and anti-aromatase 
activity of obacunone in MCF-7 breast cancer cells. Additionally, the mechanism of 
obacunone-induced inhibition of MCF-7 cell growth were explored using possible 
downstream pathways such as cell cycle arrest, apoptosis, MAPK, COX-2, and NF-κB. 
Furthermore, the uptake level of obacunone into cells was measured by HPLC and 
confirmed by LC-MS analysis.  
 
4.2 Materials and Methods 
4.2.1 Cell Lines and Culture Conditions  
Human breast cancer (MCF-7) and non-malignant immortalized breast epithelial 
(MCF-12F) cell lines were obtained from the American Type Culture Collection. The 
MCF-7 cells were cultured in DMEM medium containing 10% (v/v) fetal bovine serum, 
200 U/ml penicillin G, and 200 µg/ml streptomycin. The MCF-12F cells were cultured 
in a 1:1 mixture of DMEM and Ham‟s F12 medium with 20 ng/ml of epidermal growth 
factor (EGF), 100 ng/ml cholera toxin, 0.01 mg/ml insulin, 500 ng/ml hydrocortisone, 
and 5% (v/v) chelex-treated horse serum, and then the cells were incubated at 37 °C with 
5% CO2. Tested limonoids were dissolved in DMSO for all the in vitro studies (except 
the in vitro aromatase activity assay), and the same concentration of DMSO (< 0.2%) 
was used in the control cell group.    
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4.2.2 Cytotoxicity Assay 
The MCF-7 or MCF-12F cells (1 × 10
4
 / well) were seeded into a 96-well plate 
and allowed to adhere overnight. Cells were treated with different concentrations (10, 
50, and 100 μM) of either obacunone or obacunone glucoside for 24, 48, and 72 h. 
Tamoxifen, a well-known anti-estrogen drug used for breast cancer therapy, was used as 
a positive control. After the various time points, 10 μl of the MTT (5 mg/ml) reagent 
were added to each well and incubated for 2 h at 37 °C. After 2 h incubation, the media 
was removed and 200 μl of DMSO were added to dissolve the purple formazan. The 
absorbance was measured by an ELISA microplate reader (BioTek Instruments, 
Winooski, VT) at 570 nm. The MTT reduction was calculated as follows: (A of 
experimental group / A of control group) × 100.  
 
4.2.3 Flow-Cytometry Analysis 
Exposure of anti-cancer agents may induce apoptosis following cell cycle arrest, 
in order to demonstrate the mechanism of anti-proliferation, obacunone was used to 
analyze the cellular DNA content using flow-cytometry. The MCF-7 (1 × 10
6
) cells were 
plated into 100 mm culture dishes and allowed to attach overnight. Cells were incubated 
with a serum-free media for 24 h to synchronize and were treated with 10, 50, or 100 μM 
of obacunone for 72 h. After the 72 h incubation, cells were harvested and hypotonically 
lysed with a DNA staining solution (50 µg/ml propidium iodide, 200 µg/ml DNase-free 
RNase, 4 mM Sodium Citrate, 0.1% Triton X-100). The fluorescence was analyzed by 
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FACS Calibur (Becton Dickinson FACScan, San Jose, CA). The percentage of cells in 
each cell cycle was determined using ModFidLT V3.2.       
 
4.2.4 Western Blot  
Obacunone-treated MCF-7 cells were collected after 72 h of incubation, and total 
protein was extracted with a lysis buffer (150 mM NaCl, 10 mM Tris-Cl [pH 7.2], 0.1% 
SDS, 1% Triton X-100, 1% deoxycholate, and 5 mM EDTA) with a protease inhibitor 
cocktail (GenDEPOT, TX). Nuclear extracts were prepared using a nuclear extraction kit 
(Active Motif, Carlsbad, CA) according to the manufacturer‟s instructions. The total or 
nuclear protein concentration was determined by the bicinchoninic acid method (Pierce, 
IL). Equal amounts (25 μg per lane) of samples were subjected to 10% SDS-PAGE and 
transferred onto a PVDF membrane by semi-dry transfer (Bio-Rad, Hercules, CA). The 
membranes were blocked in 5% non-fat skim milk in a Tris-buffered saline containing 
0.1% Tween 20 (TBS-T) buffer for 1 h and then incubated overnight at 4 ºC with the 
following primary antibodies: anti-cyclin D1, anti-CDK4, anti-p27, anti-p21, anti-p15, 
anti-caspase 7, anti-cleaved caspase 7, anti-COX-2 (Cell Signaling Technology, Beverly, 
MA), anti-Bcl2, anti-Bax, anti-p38, anti-phospho p38, anti-phospho ERK, anti-phospho 
c-JNK, anti-NF-κB (RelA, p52, and p50), anti-beta-actin, and anti-GAPDH (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA). Subsequently, the membrane was washed with a 
TBS-T buffer and probed with a horseradish peroxidase conjugated secondary antibody 
for 1 h at room temperature. The protein band signal was detected by a 
chemiluminescence (ECL) detection kit (Amersham Bioscience, NJ), and the image of 
  
 
60 
6
0
 
the signal was visualized using the LAS 4000 mini-imaging system (Fuji Life Sciences, 
CT).  
 
4.2.5 In Vitro Aromatase Activity Assay 
Aromatase inhibition was evaluated using a CYP19/MCF high-throughput 
screening kit (BD Biosciences, Woburn, MA). The fluorescent intensity of fluorescein, 
the hydrolysis product of 7-Methoxy-4-trifluoromethyl coumarin (MFC), by aromatase 
was measured according to the manufacturer‟s protocol. The obacunone was dissolved 
in acetonitrile since DMSO has shown to have an effect in CYP19 inhibition. Briefly, 
obacunone and ketoconazole (as a positive control inhibitor) were placed in 96-well 
black microtiter plates (BD FalconTM) by serial dilution. The NADPH-Cofactor mixture 
(8.1 μM NADP+, 0.4 mM MgCl2, 0.4 mM glucose-6-phosphate, 0.2 U/ml glucose-6-
phosphate dehydrogenase) was added in each well and pre-incubated for 10 min at 37 
°C. After the 10 min pre-incubation of the plate, the enzyme and substrate mixture (25 
μM MFC and 1.5 pmol/well CYP19) was added to incubate for an additional 30 min at 
37 °C. The fluorescence of metabolite was measured at excitation at 405 nm and 
emission at 530 nm. Experiments were carried out in duplicate on two separate 
occasions.  
 
4.2.6 Extraction of Obacunone from MCF-7 Cell Pellet 
The cells (1 × 10
6
cells) were treated with obacunone (100 μM) and incubated for 
0, 12, 24, 48, and 72 h. After the various time points, the pellet was collected and 
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washed with PBS. To remove fatty material from pellet, 1 ml of hexane was added into 
each tube containing pellet. After 30 min sonication, the supernatant was discarded. This 
process was repeated three times. The pellet was mixed with acetone (500 μl) and then, 
the mixture was loaded onto activated C18 column cartridge. The acetone eluate was 
collected into new tube and dried for HPLC analysis.             
 
4.2.7 Quantification and Identification of Obacunone  
Extracted obacunone was quantified and identified by HPLC and LC-MS 
analysis according to method described in Section 2.   
  
4.2.8 Statistical Analysis 
All data were presented as means ± S.E., and the statistical significance of the 
data was evaluated using one-way analysis of variance (ANOVA) with Fisher‟s least 
significant difference (LSD) by the SPSS 16.0 program (Chicago, IL). P < 0.05 was 
considered significant. 
 
4.3 Results 
4.3.1 Induction of Cytotoxicity in Human Breast Cancer Cells 
To determine the cytotoxic effect of obacunone and OG on either MCF-7 or 
MCF-12F cells, mitochondrial dehydrogenase activity was measured by 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (100). Both obacunone 
and OG significantly inhibited the cell proliferation in a dose-dependent manner. As 
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shown in Fig. 4.1, treatment with obacunone and OG resulted in 44% (P < 0.01) and 
25% (P < 0.01) at 200 μM for 72 h, respectively. However, treatment with the same 
concentration of obacunone and OG for 72 h did not show cytotoxicity in MCF-12F 
non-malignant cells. Tamoxifen was used as a positive control and significantly 
inhibited the MCF-7 and MCF-12F at 25μM (Fig. 4.1). 
 
 
 
Fig. 4.1 Effect of obacunone and obacunone glucoside on cell proliferation. MCF-7 and 
MCF-12F cells were treated with 0 (DMSO, as vehicle control), 25, 50, or 100 μM for 
72 h. Dose-dependent effects of (A) obacunone, (B) obacunone glucosides, or (C) 
tamoxifen (positive control) were examined by MTT assay. Values were expressed as 
mean ± S.E. of three independent experiments. The significant difference was compared 
with control by ANOVA (* P < 0.05, ** P < 0.01).    
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4.3.2 Cell Cycle Distribution and Expression of Cell Regulatory Protein 
Cell cycle arrest is often observed before cells undergo apoptosis due to DNA 
damage (142). Since obacunone showed to be more effective in inhibition, reaching a 
maximal cytotoxic of 44%, followed by OG at 25%, in MCF-7 cell growth, we 
investigated the effect of obacunone on cell cycle distribution in MCF-7 cells by flow 
cytometry. In this experiment, we used limonoids until 100 μM (as the maximum 
concentration) since the underestimated growth inhibitory effect by MTT assay (143) is 
still enough to show significant inhibition. Treatment with obacunone caused significant 
growth arrest of 77% (P < 0.05) in the G0/G1 phase of the cell cycle and an increase of 
18% (P = 0.07) in the Sub G1 phase (Fig. 4.2A). Therefore, we examined the levels of 
G0/G1 cell cycle regulatory proteins such as cyclin D1, CDKs, and CDK inhibitors. As 
shown in Fig. 4.2B, the expressions of cyclin D1 and CDK4 protein levels were 70% 
and 30% down-regulated, respectively, in a dose-dependent manner, whereas the cell 
cycle inhibitory proteins, such as p27
Kip1
, p21
Waf/Cip1
, and p15
INK4B
, were up-regulated in 
obacunone (100 μM)-treated MCF-7 cells for 72 h (Fig. 4.2C). It is worth noting that 
trends to express the level of CDK inhibitors depended on the degree of cytotoxicity of 
obacunone. For instance, p15
INK4B
 showed late response followed by expression p27
Kip1 
and p21
Waf/Cip1
 (Fig. 4.2C). Beta-actin level was confirmed for an equal amount of 
protein loading in each experiment. 
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Fig. 4.2 Obacunone induces G1 cell cycle arrest in MCF-7 cells. The cells were treated 
with 0, 10, 50, and 100 μM of obacunone for 72 h. (A) The distribution of cells in each 
cell cycle phase was measured by flow cytometry. The data are indicated as mean ± 
S.M.E. from three independent experiments. Statistically significant differences between 
the groups are indicated as * P < 0.05 or ** P < 0.01. The expression level of G1 cell 
cycle related proteins was measured by western blot using (B) anti-cyclin D1, anti-
CDK4, and (C) anti-CDK inhibitors. All bands were expressed as relative intensity using 
densitometry. The bars represent standard errors.    
A 
B C 
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4.3.3 Effect on Apoptosis and Inflammation-Signaling Molecules   
To further determine whether obacunone induces apoptosis as well as G0/G1 cell 
cycle arrest in MCF-7 cells, immunoblot analysis was performed with various apoptosis 
markers such as anti-apoptotic Bcl2, pro-apoptotic Bax, and pro- and active caspase-7 
(Fig. 4.3A). Significant decreases in expression levels of the Bcl2/Bax ratio, which is 
associated with activation of apoptosis, were observed in obacunone-treated breast 
cancer cells. The Bcl2/Bax ratio was inhibited by 40, 57, and 60% using obacunone at 
10, 50, and 100 μM, respectively. Since caspase-3 is nonfunctional in MCF-7 cells, the 
caspase-7 was evaluated as an apoptosis marker in downstream cascade by apoptosis 
signaling. When 100 μM of obacunone were used to treat MCF-7 cells, an 80% increase 
in expression level of active caspase-7 was detected.  
The family of MAPKs is associated with various diseases, and inflammation has 
been reported in several in vitro and in vivo studies. Specifically, since the 
overexpression of p38 and JNK were considered as markers of breast tumorigenesis 
(136), we tested whether obacunone-induced cell cycle arrest/apoptosis is associated 
with the alteration of the MAPK pathway in MCF-7 cells. As shown in Fig. 4.3B, 
treatment with obacunone resulted in 58% (P < 0.01) inhibition of phospho-p38 levels 
without change in the total p38 protein level. Unlike phospho-p38, obacunone treatment 
did not affect the level of phospho-ERK and phospho-c-JNK at the overall range. These 
results suggest that attenuated phospho-p38 expression level correlates with cell cycle 
arrest and apoptosis using obacunone in MCF-7 human breast cancer cells.    
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Fig. 4.3 Obacunone induces apoptosis through inhibition of p38 MAPK in MCF-7 cells. 
The cells were treated with 10, 50, and 100 μM obacunone or vehicle DMSO for 72 h. 
Cell lysates (25 μg) were analyzed by western blotting for (A) Bcl2, Bax, caspase-7 
(casp-7), cleaved casp-7; and (B) p38, phospho-p38, phospho-ERK, phospho-cJUN, and 
beta-actin. Values were normalized to beta-actin. The relative ratios were determined as 
Bcl2 to Bax, cleaved casp-7 to casp-7, and phospho-p38 to p38. The data were 
represented as mean ± S.E. (n = 3) with statistically significant differences (** P < 0.01).           
 
4.3.4 Inhibition of Aromatase Activity using Obacunone  
Increased estrogen level and aromatase enzyme activity was detected in breast 
cancer tissue (73). Therefore, we determined whether obacunone has any aromatase 
inhibitor activity. In vitro MFC aromatase screening assay was used and determined the 
converted fluorescence substrate, 7-hydroxy-4-trifluoromethyl coumarin, by CYP19. As 
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range 0.74 to 60 μM (P < 0.01). At the dose of 60 μM, the aromatase activity was 
inhibited 65.52% (P < 0.01) at maximum range. The required obacunone for 50% 
aromatase inhibition (IC50) was 28.04 μM. The ketoconazole, as a positive control, 
decreased aromatase activity with IC50 values of 0.85 μM. This value was consistent 
with the supplier. 
 
 
 
Fig. 4.4 Inhibition of aromatase (CYP19) activity by obacunone and ketoconazole 
(positive control inhibitor). Different concentrations of obacunone (0 to 60 μM by one-
third serial dilution) and ketoconazole (0 to 8 μM by one-third serial dilution) were 
incubated with 7-methoxy-4-trifluoromethyl coumarin. The aromatase activity was 
measured as described in the Materials and Methods section. Values were expressed as 
means ± S.E. (n = 4 for obacunone or 3 for ketocozazole). The significant difference was 
compared with control by ANOVA (** P < 0.01).    
 
4.3.5 Inhibition of NF-κB and COX-2 
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obacunone led us to determine the COX-2 expression level. In addition, constitutive 
activation of NF-κB and COX-2 expression is known to be a critical factor for activating 
inflammation. Also, the down-regulated aromatase activity is known to inhibit the 
MAPK pathway and attenuate the activation of NF-κB. Therefore, the down-regulation 
of p38 MAPK by obacunone led us to investigate the NF-κB translocation activity from 
the cytosolic to the nucleus in MCF-7 cells. The measurement of nuclear fraction of 
MCF-7 cells was analyzed by western blot for NF-κB (Fig. 4.5A). In this experiment, all 
three forms of NF-κB were down-regulated, and the translocation inhibition levels were 
37% (P < 0.05) of RelA, 63% (P = 0.05) of p52, and 45% (P < 0.05) at 100 μM for 72 h 
(Fig. 4.5A).   
  Since NF-κB has been reported as a transcriptional regulator of COX-2, 
experiment was conducted to determine whether obacunone treatment in MCF-7 
involves an anti-inflammatory mechanism through COX-2 inhibition. As shown in Fig. 
4.5B, obacunone treatment resulted in significant inhibition, and the inhibition rate was 
60% (P < 0.01) at 100 μM followed by 30% (P < 0.05) at 50 μM.  
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Fig. 4.5 Effect of obacunone on NF-κB activity and COX-2 expression. Cells were 
treated with indicated concentration of obacunone for 72 h, and the total protein lysates 
were analyzed by western blot with (A) COX-2, MMP-9, and beta-actin. (B) Nuclear 
extracts were analyzed by western blot with RelA, p52, p50, or GAPDH, which 
confirmed equal loading. The data were represented as mean ± S.E. (n = 3) with 
statistically significant differences (* P < 0.05, ** P < 0.01).           
 
4.3.6 In Vitro Uptake Rate of Obacunone   
To verify the absorption level and the stability of obacunone into MCF-7 cells, 
we determined the uptake level of obacunone in the cell pellet by HPLC analysis. As 
shown in Fig. 4.6A, about 13% obacunone was absorbed into MCF-7 cell as fast as 12 h 
incubation. However, the absorption level was constant during 72 h. Further, the stability 
of obacunone during the incubation was determined using LC-MS analysis. The LC-MS 
result indicated that obacunone is stable in the cell pellet for 72 h (Fig. 4.6B).   
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Fig. 4.6 Uptake rate of obacunone in MCF-7 cells. The Cells were treated with 
obacunone (100 μM) during indicated time period, and the cell pellet was extracted with 
chloroform as described in the Materials and Methods section. (A) The obacunone 
concentration present in pellet was quantified by HPLC. (B) The compound stability was 
measured using 72 h incubated-pellet fraction by LC-MS. 
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4.4 Discussion 
Development of medicinal drugs has shown a trend toward the use of naturally 
occurring products as therapeutic agents or disease preventatives due to safety concerns. 
For instance, several clinical researchers have reported side effects, such as increased 
risk of cardiovascular disease, leukopenia, and liver toxicity (144), associated with well-
known hormonal treatments, such as tamoxifen and aromatase inhibitor. Therefore, the 
use of natural compounds from plant product such as limonoids, abundantly present in 
citrus fruits, has been investigated due to their synergistic effect as disease-preventive 
agents (9, 12, 145).  
In this current study, we demonstrated for the first time that obacunone, a natural 
compound from citrus, significantly inhibits estrogen-dependent breast cancer cell 
proliferation through inhibition of the p38 MAPK signaling pathway. The stimulated 
cytotoxicity of obacunone resulted in cell cycle arrest as well as apoptosis, or more 
specifically, a significant suppression of aromatase activity affected by suppression of 
NF-κB and COX-2 expression. The cytotoxic effect of obacunone did not affect non-
malignant breast cell growth.     
Lam et al. (146) demonstrated that obacunone has potential as a GST enzyme 
inducer in the forestomach, liver, and small intestine in animal models. Later, the effect 
was elaborated in other in vivo studies using rat models by demonstration enhancing 
detoxifying enzymes such as GST and QR by obacunone, thereby suppressing the 
formation of aberrant crypt foci (ACF) in azoxymethane (AOM)-induced colon cancer in 
rats (49, 147). In addition, previous studies from Patil‟s lab and others have shown the 
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cytotoxic effect in neuroblastoma, colon, pancreatic, and leukemia cancer cells (51, 55, 
116, 148). The present study showed the significant inhibition of MCF-7 cell 
proliferation through the G0/G1 phase cell cycle arrest and apoptosis (Fig. 4.1-4.3).  
The MAPK pathway is one of the important regulatory mechanisms to regulate 
cell growth and inflammation (67, 149). Accumulating data reported that the 
overexpression of MAPKs has been associated with malignancy of breast tissue (136, 
150). This led us to consider the MAPK as a potential convergent target for breast cancer 
prevention using obacunone. Present result clearly showed the inhibition of p38 MAP 
kinase by obacunone at 50 μM and over (Fig. 4.3B). However, we did not see any 
significant change in other MAPK family members (Fig. 4.3B). This result was 
surprising because our recent study showed that obacunone was a significant inducer of 
p38 MAPK activity in a cardiovascular model (120). This contradictory role of 
obacunone in breast cancer and the cardiovascular system supports the notion that the 
major breast cancer treatment drugs, such as tamoxifen, letrozole (AI), and anastrozole 
(AI), increase the risk of cardiovascular diseases (144, 151). The increased estrogen 
hormone being linked with protective cardiovascular disorder obviously explains this 
contradiction. However, present data are not sufficient enough to explain the complex 
cross-talk between the several signaling pathways bridging breast cancer and 
cardiovascular disease. These results suggest that obacunone may have an estrogen-
lowering effect in ER-dependent cancer cells and may lead to suppression of cell 
proliferation through attenuated p38 MAPK phosphorylation. 
  
 
73 
7
3
 
Since the imbalanced estrogen hormone causes breast cancer, a higher estrogen 
and estrogen-receptor level is considered the key biomarker of the risk of breast cancer 
(73, 151). Aromatase (CYP19) is one of the members of the cytochrome p450 
superfamily, responsible for synthesizing estrogen from androgen (130). Therefore, 
blocking aromatase enzyme activity was considered a target mechanism to prevent 
breast cancer. Obacunone exhibited significant aromatase enzyme inhibition in vitro (Fig. 
4.4). We also showed the significant down-regulation of COX-2 using treatment with 
obacunone in MCF-7 cells (Fig. 4.5B). This is consistent with previous reports of the 
positive correlation between COX-2 and aromatase enzyme activity (152). Moreover, 
the suppression of aromatase and COX-2 led to increased levels of cell cycle regulatory 
genes such as p21, p27, and p15 (Fig. 4.2B and 4.2C). Present data support studies that 
the decreased Bcl2 and cyclin D1 and increased cyclin inhibitors (p21 and p27) be 
induced by deprivation of estrogen level (153, 154).  
The transcriptional activity of NF-κB has been implicated as the key mediator in 
regulation of cell proliferation and immune and inflammatory processes (137). The NF-
κB/Rel family member following NF-κB1 (p105/p50), NF-κB2 (p100/p52), p65 (RelA), 
RelB, and c-Rel is one of the crucial transcription factors (155). The typical NF-κB 
complex is the p65/RelA heterodimer, which stimulates transcription, whereas the p50 
and p52 subunits serve primarily to bind to DNA (156). The distinct role of evidences 
suggests that the expression of pro-inflammatory markers COX-2 and iNOS is 
responsible for the transcriptional activity of NF-κB because of the presence of the 
putative NF-κB binding site on the COX-2 promoter region (157). Present data 
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demonstrated the inhibition of different types of NF-κB translocation from the cytosol to 
the nucleus using obacunone (Fig. 4.5A). These data support the evidence of the direct 
entanglement of signaling regulation between NF-κB, COX-2, and MAPK pathways by 
extracellular stimuli, stress signals, or inflammatory processes. The present study 
demonstrate that the block in cell cycle progression and apoptosis may be due to the 
inhibition of p38 MAPK and continued suppression on its downstream pathways, such 
as NF-κB, COX-2, the aromatase enzyme, and CDK inhibitors.  
In conclusion, the cancer preventive effect of obacunone was demonstrated. 
Furthermore, inhibition of p38 MAPK, an upstream target to regulate the downstream 
pathways such as NF-КB, COX-2, CYP19, cyclin D1, and CDK inhibitors in human 
breast cancer cells (Fig. 4.7), was demonstrated. Further in vivo or clinical studies may 
be needed, but the findings in this research may be useful for understanding the role of 
natural products as cancer prevention mechanisms in breast cancer.   
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Fig. 4.7 Proposed model for signaling pathway leading to growth inhibition by 
obacunone in estrogen-responsive breast cancer (MCF-7) cell. The obacunone inhibits 
p38 phosphorylation, which activates NF-κB translocation from the cytosolic to the 
nucleus. The positive regulatory downstream targets COX-2 and CYP19 are attenuated 
due to the inhibition of NF-κB activation. The aromatase inhibition by sequential 
inhibitory effect decreases the cyclin D and CDK 4/6. Sequentially, the increased CDK 
inhibitors (p21, p27, and p15) inhibit the cell cycle progression. In addition, the 
decreased Bcl2/Bax ratio, which indicated mitochondrial dysfunction and activated 
caspase-7, indicates the apoptosis in MCF-7 cells.   
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5. STRUCTURE-FUNCTION RELATIONSHIPS OF LIMONOIDS ON P38 
MAP KINASE ACTIVITY IN HUMAN AORTIC SMOOTH MUSCLE 
CELLS*
3
 
 
 
5.1 Introduction 
Citrus fruits contain different groups of health promoting compounds such as 
flavonoids, ascorbic acid, vitamins, carotenoids, limonoids, and pectin (6). Among these 
health promoting compounds, tetranorterpenoid derivatives called limonoids are unique 
bitter compounds mostly present in citrus and neem (158). Accumulating evidences 
suggest that limonoids reduce the risk of diverse spectrum of diseases including cancer 
(15, 49, 52), cardiovascular (41, 159), and neurodegenerative disease (51). Previous 
studies suggest that the presence of furan and an intact A-ring of limonoids are 
associated with increasing chemopreventive activity in cancer cells (47, 63). While 
current evidences suggest that chemical structure of citrus limonoids play a critical role 
in reducing risk of certain cancers, very little information is available about the effects of 
limonoids on cardiovascular cells.  
Pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, and IL-12, and 
tumor necrosis factor-α (TNF-α) play an important role in the regulation of 
inflammatory mechanisms in mammalian cells (67, 68). However, overproduction of 
these cytokines have been implicated in inducing a variety of chronic cardiovascular 
                                                 
* Reprinted with permission from “Structure-Function Relationships of Citrus Limonoids on p38 MAP 
Kinase Activity in Human Aortic Smooth Muscle Cells” by Jinhee Kim, Guddadarangavvanahally K. 
Jayaprakasha, Mariappan Muthuchamy, and Bhimamagouda S. Patil, 2011. European Journal of 
Pharmacology, 670, 44-49, Copyright 2011 by Elsevier B.V. 
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diseases such as atherosclerosis, coronary artery disease, arrhythmia, heart failure, 
hypertension, and ischemia (68, 70). Since the TNF-α is regulated by the p38 mitogen-
activated protein (MAP) kinase signalling cascade (160), the regulation of the p38 MAP 
kinase signal transduction pathway is a significant target for anti-inflammatory therapy. 
Indeed, accumulating evidences suggest that up-regulation of p38 is associated with the 
development of human cardiovascular disease (161, 162). Therefore, p38 MAP kinase is 
one of the important central targets for therapeutic approaches in controlling human 
cardiovascular disease. Although synthetic p38 inhibitors are commercially used in 
cardiovascular disease treatments, clinical trials are still ongoing due to side effect 
(mainly hepatotoxicity) and the interruption of other signalling pathways (163). 
Therefore, there is a critical need for potential natural bioactive compound, such as 
limonoids, which distinctly suppress p38 MAP kinases without any side effects.  
 We have previously shown that limonoids decrease proliferation of cancer cells 
(16, 51, 52, 118). Several studies have demonstrated that p38 MAP kinase pathway is 
one of the primary determinants in modulating cell cycle signalling and inflammation 
(67, 70). Hence, we have hypothesized that limonoids will have an effect on p38 MAP 
kinase activity in cardiovascular cells. Therefore, the present study was aimed to 
determine the effect of citrus limonoids on p38 MAP kinase activity in human aortic 
smooth muscle cells (HASMCs). In addition, structure-function relationships were 
investigated using seven limonoids to determine which functional groups of limonoids 
and/or how many numbers of ring structures in limonoids are essential in modulating 
p38 MAP kinase activity.  
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5.2 Materials and Methods 
5.2.1 Materials 
HASMCs, smooth muscle cell medium (SMCM), and SMC growth supplement 
were purchased from ScienCell (Carlsbad, CA, USA). Super Signal West Femto 
chemiluminescence substrate and BCA protein assay kit were purchased from Pierce 
(Pierce, IL, USA). Anti-p38 MAPK (sc-7972), anti-phospho p38 MAPK (sc-7973), and 
anti-β-actin (sc-81178) monoclonal antibodies were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). Recombinant human TNF-α was obtained from 
R&D systems (Minneapolis, MN, USA). A chemiluminescence (ECL) detection kit was 
obtained from Amersham Pharmacia (Piscatawa, NJ, USA), and PVDF membrane was 
obtained from Bio-Rad (Hercules, CA, USA). All other reagents were analytical grades 
and obtained from Fisher Scientific (Atlanta, GA, USA). 
 
5.2.2 Cell Culture 
The HASMCs were cultured in SMCM containing a growth supplement at 37 ºC 
in a humidified atmosphere of 5% CO2 in an incubator. HASMCs were grown to 80-
90% confluence, and cell passage 4-6 was used for all the experiments. For treatments, 
cells were serum starved for 24 h. After the 24 h incubation, the cells were provided with 
fresh media that contained limonoids at different concentrations (12.5 to 50 mM) and the 
incubation was continued for 72 h without changing the media. Control cell group was 
treated with appropriate concentration of DMSO, which was used for solubilizing the 
limonoids.  
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5.2.3 Western Blot 
HASMCs were collected at the end of appropriate incubation period and the cell 
pellet was washed with PBS containing phosphatase inhibitors and lysed in a protein 
lysis buffer containing 150 mM NaCl, 10 mM Tris-Cl, pH 7.2, 0.1% SDS, 1% Triton X-
100, 1% deoxycholate, and 5 mM EDTA and with a protease inhibitor cocktail 
(GenDEPOT, TX, USA)). Protein concentration was determined by the BCA method. 
Equal amount of protein (30 µg) was separated by 10% SDS-PAGE, and the gel was 
blotted onto a PVDF membrane by semi-dry transfer (Bio-Rad, Hercules, CA, USA). 
The membranes were blocked with 5% non-fat dry milk in a Tris-buffered saline 
containing 0.1% Tween 20 (TBST) buffer for 1 h and then incubated overnight at 4 ºC 
with primary mouse IgG anti-p38 (1:800) and primary mouse IgM anti-pp38 (1:500). 
After being washed four times for 5 min with the TBST buffer, the membrane was 
continuously incubated with a horseradish peroxidase conjugated secondary antibody 
(1:2500). The protein band signal was detected by either ECL (β-actin and p38) or Super 
Signal West Femto chemiluminescence (pp38). To reprobe the membranes with an anti-
β-actin antibody, membranes were incubated with a stripping buffer (100 mM 2-
Mercaptoehtanol, 62.5 mM Tris-HCl (pH 6.7), 2% SDS) for 30 min at 50 ºC. 
Sequentially, blocking the membrane with 5% non-fat dry milk in TBST buffer for 1 h 
was done, and then the immunodetection protocol was repeated. The protein levels and 
densitometry were analyzed by LAS 4000 mini (FUJI Film, Tokyo, Japan). Western blot 
analyses of HASMCs proteins followed by quantification were performed three times for 
each sample and the resulting mean ± standard error of mean (S.E.) was calculated. 
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5.2.4 Statistical Analysis 
All data were presented as means ± S.E. of at least three independent 
experiments. The data was determined using one-way analysis of variance (ANOVA) 
with Student‟s t-test by the SPSS 16.0 program (Chicago, IL). P < 0.05 was considered 
significant. 
 
5.3 Results  
5.3.1 Differential Inhibition of p38 MAP Kinase Activity by Parent and Defuran 
Limonoids  
 The typical structures of citrus limonoids consist of five rings termed as A, A', 
B, C and D (Fig. 5.1 and 5.2). Nomilin differs from limonin in the absence of the A' ring 
and furan ring has been removed from nomilin and limonin to generate defuran nomilin 
and defuran limonin, respectively (Fig. 5.1 top panel). Nomilin and deacetyl nomilin 
consists of saturated seven- membered ring with one asymmetric center at C-1 position 
(Fig. 5.2A). Moreover, C-1 position was attached with acetoxy group in nomilin whereas 
hydroxyl group present in deacetyl nomilin. As seen in Fig. 5.2A, methyl nomilinate is 
similar to nomilin except „A‟ ring is opened and C-3 position is methylated. Obacunone 
has unsaturated double bond between C-1 and C-2 position.   
To investigate the role of furan ring on p38 MAP kinase activity, HASMCs were 
treated with limonin, nomilin, defuran limonin and defuran nomlin at various 
concentrations. At 50 mM concentration, limonin, nomilin, and defuran nomilin 
exhibited significant decrease in p38 MAP kinase activity by 19%, 38% and 17%, 
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respectively; whereas defuran limonin did not show any significant effect on p38 MAP 
kinase (Fig. 5.1). Nomilin that possesses seven-membered A ring with acetoxy group 
showed significant suppression of p38 MAP kinase activity when compared with the 
defuran nomilin (38% versus 17%, respectively) (Fig. 5.1B).  
 
 
Fig. 5.1 Effect of furan moiety on p38 MAP kinase activation in HASMCs. (Top panel) 
Structure of purified and modified at the side chains of limonoids. The cells were 
incubated with various concentrations of (A) limonin and defuran limonin, and (B) 
nomilin and defuran nomilin, for 72 h. p38 MAP kinase activity was evaluated by 
western blots as described in the Methods section. β-actin was used as the loading 
control. The bar graphs represent the mean ± S.E. of three independent experiments. * P 
< 0.05, # P < 0.05, ## P < 0.01 by ANOVA. 
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5.3.2 Differential Effects on the p38 MAP Kinase Activity by Seven-Membered A Ring 
Limonoids 
To further determine the effects of substitution of seven-membered with different 
functional groups on p38 MAP kinase activity, four different A ring compounds at 
various concentrations were tested on HASMCs.  
 
 
Fig. 5.2 Effect of A-ring modifications on p38 MAP kinase activation in HASMCs. (A) 
Structure of purified limonoids containing slight A-ring modifications. The cells were 
incubated with (B) nomilin and A-ring modified compounds under the indicated 
concentrations for 72 h. The expression of total and phospho p38 MAP kinase was 
examined by western blots. β-actin was used as the loading control. Data represent the 
mean ± S.E. of three independent experiments. * P < 0.05, # P < 0.05, ## P < 0.01 by 
ANOVA. 
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At 50 µM concentrations, while the parent molecule nomilin decreased p38 MAP 
kinase activity by 38%, deacetyl nomilin showed a 19% inhibition of p38 MAP kinase 
activity (Fig. 5.2). In contrast, obacunone increased p38 MAP kinase activity by 38% 
and methyl nomilinate, which possesses an open A ring structure, did not show any 
effect on p38 MAP kinase. 
 
5.3.3 Nomilin Inhibits TNF-α Induced p38 MAP Kinase Activity in HASMCs 
The phosphorylation of the p38 MAP kinase is mediated through pro- 
inflammatory molecule, TNF-α. Therefore, the most active limonoid, nomilin, was 
examined to elucidate its effect on TNF-α induced p38 activity in HASMCs. 
  
 
Fig. 5.3 Nomilin inhibits TNF-α induced p38 MAP kinase activity in HASMCs. The 
cells were pretreated with 0.1% DMSO (vehicle) or nomilin (50 µM) for 1 h and then 
stimulated by TNF-α (100 ng/ml) for 6 and 12 h. Cell extracts were analyzed using 
western blot with anti-p38, anti-phospho-p38, and anti-β-actin. β-actin was used as the 
loading control. Data represent the mean ± S.E. of three independent experiments. * P < 
0.05, ** P < 0.01 by ANOVA. 
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The cells were pretreated with 50 mM of nomilin for 1 h and then exposed to 
TNF-α for 6 and 12 h (Fig. 5.3). Pretreatment of nomilin completely suppressed the 
TNF-α induced phosphorylation of p38 MAP kinase activity as early as 6 h. The 
maximum p38 MAP kinase inhibition activity (31%) could be seen at 6 h, and the 
inhibitory activity (21%) could be sustained at 12 h (Fig. 5.3).  
 
5.4 Discussion  
The data clearly demonstrated for the first time that citrus limonoids are potent 
inhibitors for p38 MAP kinase activity in HASMCs. Structure-function studies of seven 
limonoids revealed that nomilin is the most potent inhibitor of p38 MAP kinase. In 
addition, nomilin completely inhibits the TNF-a induced p38 MAP kinase activity in 
HASMCs.  
  In recent years, several studies from Patil‟s laboratory and other groups indicate 
that limonoids have strong positive effects on different types of cancer cells by inhibiting 
cell proliferation (16, 53, 164), inducing apoptosis (36, 140), arresting cell cycles (7), or 
increasing detoxifying enzymes (64). In addition, using in vivo model systems it has 
been shown that limonoids significantly reduce the tumor size (49, 50). Recently, in vivo 
studies demonstrated no risk of toxicity in using limonin and nomilin (165). Although 
numerous epidemiological studies demonstrate that the risk of cardiovascular disease 
and fruit consumption have inverse relationship (166-168), the specific mechanism of 
actins using citrus bioactives remains to be elucidated.  
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Accumulating evidences demonstrate that several kinases such as MAP kinases, 
phosphoinositide 3-kinase (PI3K)/Akt, and the small GTPase Rho/Rho kinases (ROCKs) 
play significant roles in modulating human cardiovascular diseases (169, 170). These 
kinases are central hierarchies in various signalling pathways that have been 
demonstrated in various physiological functions including protein phosphorylation, cell 
adhesion, cell survival, and cell contraction (170). Although these pathways are 
regulated by complex interactions and cross-talking with other signal transduction 
pathways, the regulatory mechanisms in a specific cell, downstream substrates, and 
outcomes of responses are highly specialized to each cell type. As possible downstream 
targets of PI3K/Akt and ROCK pathway, MAP kinases play a convergent role in the 
modulation of the heart disease processes (169). The three major MAP kinase 
subfamilies in mammalian cells are the extracellular signal regulated kinases (ERK1/2), 
the c-Jun N-terminal kinases (JNKs), and the p38 MAP kinase (67). In particular, it has 
been demonstrated that p38 MAP kinase plays a central role in the regulation of human 
cardiovascular diseases (171). Elevated p38 MAP kinase activity was shown in failing 
human heart secondary to ischemic cardiomyopathy but the activity of ERK1/2 was 
unchanged (172). Furthermore, an increase in p38 kinase activity was reported in 
collagen- or thrombin-induced activation of human platelet (173, 174). In addition, p38 
inhibitors have been shown to inhibit collagen- or thrombin-induced platelet aggregation 
(175) and cardiac hypertrophy in rat model (163). In the present study, we have shown 
that citrus limonoids are potent p38 MAP kinase inhibitors in HASMCs. Since p38 MAP 
kinase pathway plays a central role in inflammation, one of the key mediators in 
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cardiovascular diseases, citrus limonoids can modulate such pathway to reduce the risk 
of cardiovascular diseases. However, further experiments are warranted to test the effect 
of limonoids on various down-stream signalling cascades of p38 MAP kinase activity.  
Most of the citrus limonoids contain a furan ring at C-17 position. The existence 
of furan ring has been thought to play an important role in biological activity. Limonoids 
are thermally stable and the melting point is 298-300 °C (101). Limonin is stable over a 
wide range of pH at 2-9, but completely degraded at pH 10-12 (29). Patil‟s group have 
isolated and identified several limonoids at different temperatures and purified by 
various methods (58, 117, 123) and the change in furan ring was not observed. 
Therefore, the functional groups including furan ring will be stable during isolation 
process.  
A study about structure-activity relationships of limonin on anti-feedant activity 
demonstrated that the furan ring and epoxy group have the highest activity against insect 
(62). Lam et al. have shown that the furan moiety is critical to enhance glutathione S-
transferase (GST) enzyme activity in various organs using animal models (63, 146, 176). 
Additionally, our recent in vivo study demonstrated that defuran limonin lost its ability 
to induce GST enzyme activity (47). Present study also demonstrated that defuran 
nomilin inhibited the p38 MAP kinase activity by 17%, while the parent molecule 
(nomilin) showed 38% inhibition. Interestingly, defuran limonin did not show inhibition 
but parent molecule (limonin) showed 19% inhibition of p38 MAP kinase activity. 
Therefore, this data indicate that the existence of the furan ring has a potential impact to 
increase the inhibition of p38 MAP kinase activity. In addition, nomilin exhibited a 
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greater inhibition of p38 MAP kinase compared to limonin (38% versus 19%). It is 
possible that seven-membered A ring in nomilin plays a key role in inhibition of p38 
MAP kinase activity. The p38 MAP kinase inhibition activity of the different limonoids 
(Fig. 5.1 and 5.2) are ranked in the following order: nomilin (38%) > limonin (19%) = 
deacetyl nomilin (19%) > defuran nomilin (17%). Defuran limonin and methyl 
nomilinate have no activity on p38 MAP kinase. These data suggest that the p38 MAP 
kinase suppression by specific limonoids is more affected by the seven-membered A 
ring with acetoxy group and the furan moiety. In contrast, obacunone, which has a 
double bond in the A-ring, promotes p38 MAP kinase activity in HASMCs. These 
results seem to suggest that, saturation of ring A by an acetyl group at the C-1 position 
of nomilin will change in the conformation of large part of the molecule and it leads to 
significant p38 MAP kinase inhibition. Obacunone has also been reported as one of the 
most potent limonoids in reducing the risk of carcinogen induced cancer in animal model 
(49). Thus, it is critical to understand the role of double bond in the seven-membered A 
ring compound on the modulation of p38 MAP kinase activity in cancer and 
cardiovascular cells.  
TNF-α production is mediated by macrophages and the neointimal vascular 
region as an inflammatory response after damage in the cardiovascular region (177, 
178). Furthermore, TNF-α is present in the human arterial wall and its activation initiates 
the progression of atherosclerosis (178). Currently, the TNF-α antibody, infliximab, and 
anti-inflammatory drugs such as aspirin, indomethacin, and ibuprofen are prescribed for 
the treatment of inflammatory disorders, including cardiovascular disease (179, 180). In 
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the present study, phosphorylation of p38 MAP kinase induced by TNF-α in HASMCs 
was completely blocked by nomilin, suggesting that nomilin may potentially be involved 
in the anti-inflammatory response of citrus fruits by preventing phosphorylation of p38 
MAP kinase cascade in HASMCs.  
In conclusion, these data demonstrated that certain citrus limonoids inhibited p38 
MAP kinase activity and the activity was affected by the existence of a furan ring and A 
ring modification. Specifically, nomilin, which has seven-membered A ring with 
acetylation at the C-1 position as well as a furan ring, showed a greater inhibition of p38 
MAP kinase activity in both HASMCs and TNF-α induced HAMSCs. Future studies 
addressing the effect of limonoids on the down-stream signalling cascades of p38 MAP 
kinase in cardiovascular cells will provide additional insights in understanding the 
biological and physiological roles of limonoids for cardiovascular disease prevention.  
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6. NOMILIN INHIBITS THE TNF-α-INDUCED HUMAN AORTIC SMOOTH 
MUSCLE CELL PROLIFERATION THROUGH MITOCHONDIRAL- 
DEPENDENT PATHWAY 
 
6.1 Introduction 
The limonoids demonstrate biochemical and biological effects in reducing risks 
against cancer(9, 181), cardiovascular disease (182), and degenerative disease (181, 
183). In addition citrus limonoids also exhibit anti-malarial, anti-fungal, and anti-viral 
activities (181, 184). Additionally, our previous in vivo and in vitro research showed that 
limonoids induce phase II enzymes (glutathione S-transferase and quinone reductase) 
(185-188) and inhibited cell proliferation of MCF-7 breast cancer  (16, 189), HT-29 
colon cancer (190), panc-28 pancreatic cancer (191, 192), and SH-SY5Y neuroblastoma 
cells (183). Furthermore, certain limonoids induced apoptosis in rats through the 
suppression of anti-inflammatory proteins such as inducible nitric oxide synthase (iNOS) 
and cyclooxygenase (COX)-2 (49, 50).  
Atherosclerosis is initiated by chronic inflammatory processes such as 
endothelial injury, modification of lipoprotein by a long-term oxidation process, 
adhesion of blood monocytes, lymphocytes, and platelets to the artery walls, and 
proliferation of smooth muscle cells (SMCs) (77). Previous research has suggested that 
SMCs are closely related to the initiation of atherosclerosis and are involved in every 
type of lesion during the disease‟s progression (193). In addition, it has been suggested 
that the SMCs are considered the origin for secretion of important inflammatory 
molecules such as the transforming growth factor (TGF)-β, platelet derived growth 
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factors, macrophage inhibitor factor (MIF), chemokines, interferon gamma, and 
monocyte chemoattractant protein (MCP-1), which play a role in the development of cell 
proliferation and cell migration as well as extracellular matrix (ECM) production in 
atherosclerosis (193). In addition, SMCs have an anti-apoptotic effect on monocytes 
through increased Bcl2, AKT, and MAPK. These evidences suggest the possibility that 
induction of SMC apoptosis in the early stages may result in the prevention of 
atherosclerosis (194). The SMCs are involved throughout the development of 
atherosclerosis, and the proliferation of SMCs is a key feature of development of the 
early atherosclerosis stage (77). Inflammatory responses continuously stimulate the 
migration and proliferation of SMCs, which results in accumulation of ECM and the 
thickening of the artery wall (78). 
To the best of my knowledge, very little information is available related to 
limonoids and anti-inflammatory properties. To explore the possible role of limonoids, 
nomilin was evaluated for the anti-proliferative activity against TNF-α induced human 
aortic smooth muscle cells (HASMCs), and the possible mechanism of growth-inhibition 
was elucidated. 
 
6.2 Materials and Methods 
6.2.1 Materials 
Dulbecco‟s Modified Eagle Medium (DMEM); trypsin-EDTA; penicillin; 
streptomycin; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT); and 
dithiothreitol (DTT). HASMCs, smooth muscle cell medium (SMCM), and SMC growth 
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supplement were purchased from ScienCell (Carlsbad, CA, USA). Mouse monoclonal 
anti-Bax (sc-7480), anti-Bcl2 (sc-65392) and anti-β-actin (sc-81178) were obtained from 
Santa Cruz Biotechnology (Santa Cruz, CA). Nomilin was purified and identified as 
described in Section 2.  
 
6.2.2 Cell Culture and Cytotoxicity Assay 
The HASMCs were cultured in SMCM containing a growth supplement followed 
by previously described in Section 5. For MTT assay, cells (0.5 × 104/well) were seeded 
into a 96-well plate and allowed to grow overnight. Next day, the cells were serum 
starved for 24 h. After the 24 h incubation, the cells were pretreated with 0.1% DMSO 
(vehicle) or nomilin (50 µM) for 1 h and then stimulated by TNF-α (20 ng/ml) for 12 
and 24 h. At the end of the treatment period, 10 μl of MTT (5 mg/ml in PBS) solution 
was added into each well, and then the plate was incubated at 37 °C for 2 h. After the 
incubation, the media was removed, and 200 μl DMSO was added to dissolve the 
formazon; the absorbance values read 570 nm on the KC4 microplate reader (BioTek 
Instruments, Winooski, VT).      
 
6.2.3 Western Blot 
For western blot, HASMCs (0.5 × 10
6
) cells were seeded into 6 well plates and 
serum starved for 24 h. After the serum starvation, either 0.1% DMSO or nomilin (50 
μM) was pretreated into HASMCs cells and then stimulated by TNF-α (20 ng/ml) for 12 
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and 24 h. After the incubation time, cells were harvested and lysed. Protein expression 
level was measured by western blot according to described in Section 2.  
 
6.3 Results and Discussion 
Since the proliferation of SMCs is a key feature of development of 
cardiovascular disease (78), the purified nomilin was evaluated for the effect on TNF-α 
induced HASMCs proliferation. As shown in Fig. 6.1, HASMCs proliferation was 
significantly induces by treatment of TNF-α (20 ng/ml) for 24 h. Nomilin was 
significantly inhibited the TNF-α induced proliferation. The activated proliferation by 
TNF- α was returning back to normal stage by pre-treatment of nomilin.   
 
 
Fig. 6.1 Nomilin inhibits the TNF-α induced HASMCs proliferation. The cells were 
incubated with DMSO or nomilin (50 μM) for 1 h and then activated with TNF-α (20 
ng/ml) for 23 h.  The HASMCs proliferation was determined using MTT assay. The bar 
graphs represent the mean ± S.E. of three independent experiments. The bar graph with 
different alphabet is significantly different at P < 0.05 by ANOVA. 
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To determine the induction of apoptosis, the Bcl2 and Bax protein level were 
evaluated by western blot. The decreased ratio of Bcl2/Bax is suggested to be involved 
in the apoptosis process and is representative of the mitochondrial dependent apoptosis 
marker. The TNF-α induced HASMCs exhibited 70% increased Bcl2/Bax ratio, while 
nomilin treatment depicts 50% decreased Bcl2/Bax than DMSO (vehicle control) 
treatment (Fig. 6.2).    
 
 
 
 
Fig. 6.2 Nomilin inhibits TNF-α induced HASMCs proliferation by mitochondrial-
dependent pathway. The cells were incubated with DMSO or nomilin (50 μM) for 1 h 
and then activated with TNF-α (20 ng/ml) for 23 h. The protein expression level was 
detected by western blot analysis. Beta-actin was used for loading control.  
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Several in vitro and in vivo studies proved that citrus bioactive components have 
antioxidant, prevention of cancer, degenerative disease and cardiovascular disease (12). 
However, the mechanism by which limonoids inhibit cardiovascular disease is warranted. 
studied. In the Section 5, results demonstrated that nomilin inhibit the TNF-α induced 
p38 MAPK activity in HAMSCs. Since the SMCs are thought to be a principle cell 
involved in development of cardiovascular disease, this present study was conducted to 
elucidate the further mechanism of nomilin in TNF-α induced HAMSCs. Nomilin 
showed significant inhibition of TNF-α induced HASMCs proliferation (Fig. 6.1).  
Dysregulation of cell growth contributes to a number of human diseases 
including cancer, cardiovascular disease, autoimmune disorders and neurodegenerative 
diseases (195). Thus, we postulated that the proliferation inhibition by nomilin might be 
due to induction of apoptosis. To test this hypothesis, the expression levels of Bcl2 and 
Bax, which are responsible for apoptosis, were measured (Fig.6.2). Nomilin decreased 
the ratio of Bcl2/Bax ratio in TNF-α induced HASMCs for 24 h. Since the decreased 
Bcl2/Bax ratio is considered to induce apoptosis due to mitochondrial dysfunction (196), 
these results demonstrated that the anti-proliferative activity of nomilin is due to 
apoptosis through mitochondrial dependent pathway. However, in order to make any 
conclusions with regard to health claim, further studies are still needed. 
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7. SUMMARY AND CONCLUSIONS 
 
The major objective of this research was to determine the health beneficial 
effects of limonoids from lemon seed and to investigate the mechanism and 
effectiveness of anti-breast cancer and anti-cardiovascular disease properties. The work 
done in this dissertation supports the following conclusions.  
Bioactive components in lemon seed extracts could be an excellent source of 
antioxidants and induce apoptosis in MCF-7 breast cancer cells through the 
mitochondrial apoptosis pathway attributed from the phosphorylation of Bax, Bcl2, 
released cytochrome C in cytosol, and cleaved PARP. Moreover, this research 
demonstrated for the first time that lemon bioactive compounds are non-toxic to non-
malignant breast cells. These findings support the hypothesis that bioactive compounds 
from lemon may have cancer-preventive properties. Therefore, purification and 
identification of compounds present in each extracts was carried out to understand their 
mechanism of apoptosis induction. 
Nine limonoids in lemon seed were purified and identified using ethyl EtOAc) 
and MeOH extracts with different types of column chromatography such as silica gel 
and ion-exchange column. The compounds were identified by employing TLC, HPLC, 
and LC-MS analytical techniques. Purified and modified limonoids, including limonin, 
nomilin, obacunone, limonexic acid (LNA), isolimonexic acid (ILNA), nomilinic acid 
glucoside (NAG), deacetyl nomilinic acid glucoside (DNAG), limonin glucoside (LG), 
obacunone glucoside (OG), limonin methoxime (LM), limonin oxime (LO), defuran 
limonin (DL), and defuran nomilin (DN), were screened for their cytotoxicity on 
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estrogen receptor (ER)-positive (MCF-7) or ER-negative (MDA-MB-231) human breast 
cancer cells. We further tested the mechanism of anti-proliferative activity of limonoids 
using in vitro aromatase enzyme assay and western blot with anti-caspase-7. Although 
most of limonoids showed anti-aromatase activity, the inhibition of proliferation was not 
related to the anti-aromatase activity. On the other hand, the anti-proliferative activity 
was significantly correlated with caspase-7 activation by limonoids. These results 
indicated that the citrus limonoid may have potential for the prevention of estrogen-
responsive breast cancer (MCF-7) via caspase-7 dependent pathways.  
Obacunone was the most potent to inhibit MCF-7 cell proliferation without 
affecting non-malignant breast cells. Treatment with obacunone also resulted in an 
increased apoptotic effect through up-regulated expression of the tumor suppressor p53, 
pro-apoptotic protein Bax, and anti-apoptotic protein Bcl2, as well as G1 cell cycle arrest 
molecules. In addition, obacunone most effectively inhibited aromatase activity in an in 
vitro enzyme assay. Exposure of MCF-7 breast cancer cells to obacunone down-
regulated expression of inflammatory molecules including nuclear factor-kappa B (NF-
κB) and cyclooxygenase-2 (COX-2). Furthermore, we also tested the possibility that 
obacunone inhibits COX-2 and NF-κB by a mechanism involving activation of the p38 
mitogen-activated protein kinase (MAPK). This study demonstrated for the first time 
that obacunone, a citrus limonoid, may have potential in the prevention of estrogen-
responsive breast cancer through inhibition of the aromatase enzyme, inflammatory 
pathways, and apoptotic markers.  
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Since up-regulation of p38 is associated with the development of human 
cardiovascular disease, we tested that eight structurally different limonoids would 
involve in inflammatory pathway via modulating p38 MAP kinase activity at various 
extent in vascular smooth muscle cells. Results demonstrated that certain citrus 
limonoids inhibited p38 MAP kinase activity and the activity was affected by the 
existence of a furan ring and A ring modification. Specifically, nomilin, which has 
seven-membered A ring with acetylation at the C-1 position as well as a furan ring, 
showed a greater inhibition of p38 MAP kinase activity in both HASMCs and TNF-α 
induced HAMSCs.  
Nomilin was significantly inhibited the TNF-α induced proliferation in HASMCs. 
Furthermore, the anti-proliferative activity of nomilin is due to apoptosis through 
mitochondrial dependent pathway. Future studies addressing the effect of limonoids on 
the down-stream signalling cascades of p38 MAP kinase in cardiovascular cells will 
provide additional insights in understanding the biological and physiological roles of 
limonoids for cardiovascular disease prevention.  
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